<html>
<head>
<META HTTP-EQUIV='Content-Type' CONTENT='text/html; charset=big5'>
<?xml version="1.0" encoding="UTF-8"?> 
<html xmlns="http://www.w3.org/1999/xhtml"
xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2017-03-09/ifrs-full"
xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
xmlns:link="http://www.xbrl.org/2003/linkbase"
xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
xmlns:xbrli="http://www.xbrl.org/2003/instance"
xmlns:xlink="http://www.w3.org/1999/xlink"
xmlns:ix="http://www.xbrl.org/2013/inlineXBRL"
xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26"
xmlns:tifrs-SCF="http://www.xbrl.org/tifrs/scf/2020-06-30"
xmlns:tifrs-ar="http://www.xbrl.org/tifrs/ar/2020-06-30"
xmlns:tifrs-bsci-ci="http://www.xbrl.org/tifrs/bsci/ci/2020-06-30"
xmlns:tifrs-es="http://www.xbrl.org/tifrs/es/2020-06-30"
xmlns:tifrs-notes="http://www.xbrl.org/tifrs/notes/2020-06-30">
<head> 
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> 
	<title> 1736 2022Q4 Financial report</title> 
	<script src="https://code.jquery.com/jquery-3.2.1.min.js" type="text/javascript"></script> 
	<script type="text/javascript"> 
		/*<![CDATA[*/ 
		function showChineseReport() { 
			$(".zh").show();
			$(".en").hide();
		}
		function showEnglishReport() {
			$(".en").show();
			$(".zh").hide();
		}
		$(document).ready(function() { 
			if (location.search.indexOf("?") != -1 && 
			location.search.split("?")[1].split("=")[1] == "en") 
				showEnglishReport(); 
			else 
				showChineseReport(); 
		});	
		/*]]>*/ 
	</script> 
	<style type="text/css"> 
		body,html {height: 100%;} 
		body {font-size: 15px;font-family: Arial;color: #000;background: #4E5869;margin: 0;padding: 0;background-color: #FFF;} 
		td,th {border: 1px solid #dddddd;padding: 5px;color: #333;background-color: #FFF;} 
		th#t1 {color: #165c98 !important;} 
		ul,ol,dl {padding: 0;margin: 0;} 
		h3 {color: #165c98;font-size: 18px;} 
		pre {font-size: 15px;font-family: Arial;} 
		.container {width: 100%;background: #FFF;margin: 0 auto;background-color: #999;} 
		.header {text-align: center;background: #165c98;margin-right: auto;color: #fff;} 
		.header > div:first-of-type {position: absolute;right: 15px;top: 15px;} 
		.header > div:nth-of-type(2) {font-size: 25px;text-align: center;line-height: 35px;} 
		.header a {text-decoration: none;margin:0 10px;color: #ffffff;} 
		.nav {float: left;width: 200px;height: calc(100% - 85px);overflow: auto;background: #fff;padding-bottom: 15px;} 
		.nav > div {padding: 10px;color: #165c98;font-size: 20px;font-weight: bold;} 
		.nav > ul {list-style: none;border-top: 1px solid #666;margin-bottom: 15px;} 
		.nav > ul li{border-bottom: 1px solid #666;} 
		.nav > ul a{padding: 5px 2px 5px 10px;display: block;text-decoration: none;background: #fff;color: #333;} 
		.nav > ul a:hover{background: #165c98;color: #fff;} 
		.content {width: calc(100% - 200px);height: calc(100% - 70px); float: left;background: #efefef;overflow: auto;} 
		.content > div[id*="link"] {height: 15px;} 
		.content table {border-collapse: collapse;margin: 0 20px;} 
		.content ul, 
		.content ol {padding: 15px 10px 10px 15px;} 
		.content table tr th {background: #7fcef5;color: #165c98;} 
		.content table tr:first-child th {background: #165c98;color: #fff;font-size: 15px;text-align: left;} 
		.content table tr:nth-of-type(odd) > td {background-color: #d3edfa;} 
		.title {font-size: 18px;font-weight: bold;margin-left: 20px;} 
		.rptidx {color: #000;margin-left: 20px;} 
		.amt {text-align: right} 
		.note {font-family: 細明體} 
		@media print{ 
			.header a{display: none;} 
			.nav{display: none;} 
			.content{width: 100%;height:auto;float: inherit;overflow: inherit;background: #fff!important;} 
			.content table{width: 100%!important;margin: 0;} 
			body{color: #000;} 
			td,th{color: #000;border: 1px solid #000;} 
		} 
	</style> 
</head> 
<body> 
	<div style="display:none"> 
		<ix:header> 
			<ix:hidden> 
				<ix:nonNumeric name="tifrs-notes:CompanyID" contextRef="From20220101To20221231">1736</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:CompanyChineseName" contextRef="From20220101To20221231">喬山健康科技股份有限公司</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:CompanyEnglishName" contextRef="From20220101To20221231">JOHNSON HEALTH TECH CO., LTD.</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Year" contextRef="From20220101To20221231">2022</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Quarter" contextRef="From20220101To20221231">4</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:ReportType" contextRef="From20220101To20221231">Financial report (general)</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:ReportCategory" contextRef="From20220101To20221231">Consolidated report</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Market" contextRef="From20220101To20221231">Listed company</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:IndustrySector" contextRef="From20220101To20221231">Commercial and industrial</ix:nonNumeric> 
			</ix:hidden> 
			<ix:references>
				<link:schemaRef xlink:href="tifrs-ci-cr-2020-06-30.xsd" xlink:type="simple"/>
			</ix:references>
			<ix:resources> 
				<xbrli:context id="From20210101To20210101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230314"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-03-14</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1736</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:unit id="TWD"> 
					<xbrli:measure>iso4217:TWD</xbrli:measure> 
				</xbrli:unit> 
				<xbrli:unit id="Shares"> 
					<xbrli:measure>xbrli:shares</xbrli:measure> 
				</xbrli:unit> 
				<xbrli:unit id="EarningsPerShare"> 
					<xbrli:divide> 
						<xbrli:unitNumerator> 
							<xbrli:measure>iso4217:TWD</xbrli:measure> 
						</xbrli:unitNumerator> 
						<xbrli:unitDenominator> 
							<xbrli:measure>xbrli:shares</xbrli:measure> 
						</xbrli:unitDenominator> 
					</xbrli:divide> 
				</xbrli:unit> 
				<xbrli:unit id="Pure"> 
					<xbrli:measure>xbrli:pure</xbrli:measure> 
				</xbrli:unit> 
			</ix:resources> 
		</ix:header> 
	</div> 
	<div class="container"> 
		<div class="header"> 
			<div> 
				<a href="javascript:showChineseReport();">中文</a>|<a href="javascript:showEnglishReport();">English</a> 
			</div> 
			<div> 
				<span class="zh">1736 喬山健康科技股份有限公司<br />2022年第4季合併財務報告</span> 
				<span class="en">1736 JOHNSON HEALTH TECH CO., LTD.<br />2022Q4 Consolidated Financial Report</span> 
			</div> 
		</div> 
		<div class="nav"> 
			<div>
				<span class="zh">財務報表索引</span>
				<span class="en">Report Index</span>
			</div> 
			<ul> 
				<li>
					<a href="#BalanceSheet">
						<span class="zh">資產負債表</span>
						<span class="en">Balance Sheet</span>
					</a>
				</li>
				<li>
					<a href="#StatementOfComprehensiveIncome">
						<span class="zh">綜合損益表</span>
						<span class="en">Statement of Comprehensive Income</span>
					</a>
				</li> 
				<li>
					<a href="#StatementsOfCashFlows">
						<span class="zh">現金流量表</span>
						<span class="en">Statements of Cash Flows</span>
					</a>
				</li> 
				<li>
					<a href="#StatementsOfChangeInEquity">
						<span class="zh">權益變動表</span> 
						<span class="en">Statements of Change in Equity</span>
					</a>
				</li>
				<span class="zh">
	    			<li><a href="#ReportOfIndependentAuditors">會計師查核（核閱）報告</a></li>
	    		</span>
	    		<span class="en">
	    			<li><a href="#ReportOfIndependentAuditorsEN">Independent Auditors' (Review) Report</a></li>
	    		</span>
				<span class="zh">
	    			<li><a style="background-color:#ceceef;">財務報表附註</a></li>
	    			<li><a href="#HistoryAndOrganization">公司沿革及業務範圍</a></li>
	    			<li><a href="#DateAndProceduresOfAuthorisationForIssueOfFinancialStatements">通過財報之日期及程序</a></li>
	    			<li><a href="#ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations">新發布及修訂準則及解釋之適用</a></li>
	    			<li><a href="#SummaryOfSignificantAccountingPolicies">重大會計政策之彙總說明</a></li>
	    			<li><a href="#SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations">會計重大判斷、假設及估計不確性之主要來源</a></li>
	    			<li><a style="background-color:#ceceef;">其它財報附註</a></li>
	    			<li><a href="#TradeAndOtherReceivables">應收款項</a></li>
	    			<li><a href="#TransactionsBetweenRelatedParties">關係人交易</a></li>
	    			<li><a href="#LoansToOthers">資金貸與他人</a></li>
	    			<li><a href="#EndorsementGuaranteeProvidedToOthers">為他人背書保證</a></li>
	    			<li><a href="#SignificantIntercompanyTransactionsBetweenConsolidatedEntities">母子公司間業務關係及重要交易往來情形</a></li>
	    			<li><a href="#NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">被投資公司名稱、所在地區…等相關資訊</a></li>
	    			<li><a href="#InvestmentInMainlandChina">大陸地區投資</a></li>
	    			<li><a href="#NonoperatingIncomeAndExpenses">營業外收入及支出</a></li>
				</span>
			</ul> 
		</div> 
		<div class="content"> 
			<!-- 資產負債表 -->
			<div id="BalanceSheet"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">資產負債表</span><span class="en">Balance Sheet</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2022年12月31日</span><span class="en">2022/12/31</span></th> 
						<th><span class="zh">2021年12月31日</span><span class="en">2021/12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">資產</span><span class="en">Assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　流動資產</span><span class="en">　Current assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1100</td> 
						<td><span class="zh">　　現金及約當現金</span><span class="en">　　Cash and cash equivalents</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,531,554</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,615,077</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1110</td> 
						<td><span class="zh">　　透過損益按公允價值衡量之金融資產－流動</span><span class="en">　　Current financial assets at fair value through profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,746</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,151</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1140</td> 
						<td><span class="zh">　　合約資產－流動</span><span class="en">　　Current contract assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentContractAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,325</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentContractAssets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">56,952</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1150</td> 
						<td><span class="zh">　　應收票據淨額</span><span class="en">　　Notes receivable, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NotesReceivableNet" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">85,444</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NotesReceivableNet" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">76,459</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1170</td> 
						<td><span class="zh">　　應收帳款淨額</span><span class="en">　　Accounts receivable, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AccountsReceivableNet" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,692,416</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AccountsReceivableNet" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,532,245</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1200</td> 
						<td><span class="zh">　　其他應收款</span><span class="en">　　Other receivables</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentReceivables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,167,768</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentReceivables" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">493,299</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">130X</td> 
						<td><span class="zh">　　存貨</span><span class="en">　　Current inventories</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Inventories" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,808,413</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Inventories" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,674,233</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1410</td> 
						<td><span class="zh">　　預付款項</span><span class="en">　　Prepayments</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentPrepayments" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">925,837</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentPrepayments" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">908,011</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1470</td> 
						<td><span class="zh">　　其他流動資產</span><span class="en">　　Other current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">155,938</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">97,455</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">11XX</td> 
						<td><span class="zh">　　流動資產合計</span><span class="en">　　Total current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">26,419,441</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,461,882</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　非流動資產</span><span class="en">　Non-current assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1517</td> 
						<td><span class="zh">　　透過其他綜合損益按公允價值衡量之金融資產－非流動</span><span class="en">　　Non-current financial assets at fair value through other comprehensive income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,444</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,494</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1518</td> 
						<td><span class="zh">　　　透過其他綜合損益按公允價值衡量之權益工具投資－非流動</span><span class="en">　　　Non-current investments in equity instruments designated at fair value through other comprehensive income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentInvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncome" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,444</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentInvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncome" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,494</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1600</td> 
						<td><span class="zh">　　不動產、廠房及設備</span><span class="en">　　Property, plant and equipment</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,494,351</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,138,726</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1755</td> 
						<td><span class="zh">　　使用權資產</span><span class="en">　　Right-of-use assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,209,517</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,614,593</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1760</td> 
						<td><span class="zh">　　投資性不動產淨額</span><span class="en">　　Investment property, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InvestmentProperty" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">38,200</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InvestmentProperty" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">40,117</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1780</td> 
						<td><span class="zh">　　無形資產</span><span class="en">　　Intangible assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,857,429</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,807,002</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1840</td> 
						<td><span class="zh">　　遞延所得稅資產</span><span class="en">　　Deferred tax assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,139,856</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,893,408</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1900</td> 
						<td><span class="zh">　　其他非流動資產</span><span class="en">　　Other non-current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">699,706</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,298,354</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">15XX</td> 
						<td><span class="zh">　　非流動資產合計</span><span class="en">　　Total non-current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,446,503</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,800,694</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1XXX</td> 
						<td><span class="zh">　資產總計</span><span class="en">　Total assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">38,865,944</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,262,576</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">負債及權益</span><span class="en">Liabilities and equity</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　負債</span><span class="en">　Liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　流動負債</span><span class="en">　　Current liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2100</td> 
						<td><span class="zh">　　　短期借款</span><span class="en">　　　Current borrowings</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ShorttermBorrowings" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,277,783</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ShorttermBorrowings" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,544,264</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2110</td> 
						<td><span class="zh">　　　應付短期票券</span><span class="en">　　　Short-term notes and bills payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentCommercialPapersIssuedAndCurrentPortionOfNoncurrentCommercialPapersIssued" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">849,648</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentCommercialPapersIssuedAndCurrentPortionOfNoncurrentCommercialPapersIssued" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,045,492</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2120</td> 
						<td><span class="zh">　　　透過損益按公允價值衡量之金融負債－流動</span><span class="en">　　　Current financial liabilities at fair value through profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">879</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2130</td> 
						<td><span class="zh">　　　合約負債－流動</span><span class="en">　　　Current contract liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentContractLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">830,872</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentContractLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">803,635</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2150</td> 
						<td><span class="zh">　　　應付票據</span><span class="en">　　　Notes payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NotesPayable" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">466,946</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NotesPayable" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">400,457</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2170</td> 
						<td><span class="zh">　　　應付帳款</span><span class="en">　　　Accounts payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,290,595</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,178,687</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2200</td> 
						<td><span class="zh">　　　其他應付款</span><span class="en">　　　Other payables</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentPayables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,567,656</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentPayables" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,062,444</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2230</td> 
						<td><span class="zh">　　　本期所得稅負債</span><span class="en">　　　Current tax liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">708,784</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">396,582</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2280</td> 
						<td><span class="zh">　　　租賃負債－流動</span><span class="en">　　　Current lease liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CurrentLeaseLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">607,062</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CurrentLeaseLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">375,873</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2300</td> 
						<td><span class="zh">　　　其他流動負債</span><span class="en">　　　Other current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,199,365</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">265,042</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2320</td> 
						<td><span class="zh">　　　　一年或一營業週期內到期長期負債</span><span class="en">　　　　Long-term liabilities, current portion</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:LongtermLiabilitiesCurrentPortion" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,024,064</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:LongtermLiabilitiesCurrentPortion" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">32,340</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2322</td> 
						<td><span class="zh">　　　　　一年或一營業週期內到期長期借款</span><span class="en">　　　　　Long-term borrowings, current portion</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentPortionOfLongtermBorrowings" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,024,064</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentPortionOfLongtermBorrowings" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">32,340</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2399</td> 
						<td><span class="zh">　　　　其他流動負債－其他</span><span class="en">　　　　Other current liabilities, others</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherCurrentLiabilitiesOthers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">175,301</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherCurrentLiabilitiesOthers" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">232,702</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">21XX</td> 
						<td><span class="zh">　　　流動負債合計</span><span class="en">　　　Total current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">24,799,590</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">21,072,476</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　非流動負債</span><span class="en">　　Non-current liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2530</td> 
						<td><span class="zh">　　　應付公司債</span><span class="en">　　　Bonds payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentPortionOfNoncurrentBondsIssued" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,000,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentPortionOfNoncurrentBondsIssued" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,000,000</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2540</td> 
						<td><span class="zh">　　　長期借款</span><span class="en">　　　Non-current portion of non-current borrowings</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">446,964</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,167,433</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2550</td> 
						<td><span class="zh">　　　負債準備－非流動</span><span class="en">　　　Non-current provisions</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">263,069</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">319,931</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2570</td> 
						<td><span class="zh">　　　遞延所得稅負債</span><span class="en">　　　Deferred tax liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">167,017</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">202,221</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2580</td> 
						<td><span class="zh">　　　租賃負債－非流動</span><span class="en">　　　Non-current lease liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinanceLeaseLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,245,219</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinanceLeaseLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">861,788</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2600</td> 
						<td><span class="zh">　　　其他非流動負債</span><span class="en">　　　Other non-current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">461,805</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">257,543</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2640</td> 
						<td><span class="zh">　　　　淨確定福利負債-非流動</span><span class="en">　　　　Net defined benefit liability, non-current</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">83,493</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">99,297</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2670</td> 
						<td><span class="zh">　　　　其他非流動負債－其他</span><span class="en">　　　　Other non-current liabilities, others</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherNoncurrentLiabilitiesOthers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">378,312</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherNoncurrentLiabilitiesOthers" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">158,246</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">25XX</td> 
						<td><span class="zh">　　　非流動負債合計</span><span class="en">　　　Total non-current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,584,074</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,808,916</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2XXX</td> 
						<td><span class="zh">　　負債總計</span><span class="en">　　Total liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">29,383,664</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,881,392</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　權益</span><span class="en">　Equity</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　歸屬於母公司業主之權益</span><span class="en">　　Equity attributable to owners of parent</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　股本</span><span class="en">　　　Share capital</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3110</td> 
						<td><span class="zh">　　　　普通股股本</span><span class="en">　　　　Ordinary share</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OrdinaryShare" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,036,166</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OrdinaryShare" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,036,166</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3100</td> 
						<td><span class="zh">　　　　股本合計</span><span class="en">　　　　Total Share Capital</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,036,166</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,036,166</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　資本公積</span><span class="en">　　　Capital surplus</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3200</td> 
						<td><span class="zh">　　　　資本公積合計</span><span class="en">　　　　Total capital surplus</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CapitalReserve" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">431,446</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CapitalReserve" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">59,979</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　保留盈餘</span><span class="en">　　　Retained earnings</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3310</td> 
						<td><span class="zh">　　　　法定盈餘公積</span><span class="en">　　　　Legal reserve</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:StatutoryReserve" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,512,422</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:StatutoryReserve" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,509,898</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3320</td> 
						<td><span class="zh">　　　　特別盈餘公積</span><span class="en">　　　　Special reserve</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:SpecialReserve" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,942,009</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:SpecialReserve" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,385,492</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3350</td> 
						<td><span class="zh">　　　　未分配盈餘（或待彌補虧損）</span><span class="en">　　　　Unappropriated retained earnings (accumulated deficit)</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:UnappropriatedRetainedEarningsAaccumulatedDeficit" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,226,611</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:UnappropriatedRetainedEarningsAaccumulatedDeficit" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,504,183</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3300</td> 
						<td><span class="zh">　　　　保留盈餘合計</span><span class="en">　　　　Total retained earnings</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,681,042</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,399,573</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　其他權益</span><span class="en">　　　Other equity interest</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3400</td> 
						<td><span class="zh">　　　　其他權益合計</span><span class="en">　　　　Total other equity interest</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherEquityInterest" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,620,071</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherEquityInterest" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,942,009</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3500</td> 
						<td><span class="zh">　　　庫藏股票</span><span class="en">　　　Treasury shares</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:TreasuryShares" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">53,612</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:TreasuryShares" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">73,872</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">31XX</td> 
						<td><span class="zh">　　　歸屬於母公司業主之權益合計</span><span class="en">　　　Total equity attributable to owners of parent</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,479,837</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">36XX</td> 
						<td><span class="zh">　　非控制權益</span><span class="en">　　Non-controlling interests</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,309</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">901,347</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3XXX</td> 
						<td><span class="zh">　　權益總額</span><span class="en">　　Total equity</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,482,280</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,381,184</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3X2X</td> 
						<td><span class="zh">　負債及權益總計</span><span class="en">　Total liabilities and equity</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">38,865,944</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,262,576</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3998</td> 
						<td><span class="zh">　預收股款（權益項下）之約當發行股數</span><span class="en">　Equivalent issue shares of advance receipts for ordinary share</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare" contextRef="AsOf20211231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3999</td> 
						<td><span class="zh">　母公司暨子公司所持有之母公司庫藏股股數（單位：股）</span><span class="en">　Number of shares in entity held by entity and by its subsidiaries</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">695,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries" contextRef="AsOf20211231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">1,028,000</ix:nonFraction> </pre></td>
					</tr> 
				</table> 
				<br /> 
			<!-- 綜合損益表 -->
			<div id="StatementOfComprehensiveIncome"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元　每股盈餘單位：新台幣元</span><span class="en">Unit: NT$ thousands　EPS Unit: NT$</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">綜合損益表</span><span class="en">Statement of Comprehensive Income</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2022年1月1日至12月31日</span><span class="en">2022/1/1To12/31</span></th> 
						<th><span class="zh">2021年1月1日至12月31日</span><span class="en">2021/1/1To12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業收入</span><span class="en">Operating revenue</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">4000</td> 
						<td><span class="zh">　營業收入合計</span><span class="en">　Total operating revenue</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Revenue" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">33,612,947</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Revenue" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,779,328</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業成本</span><span class="en">Operating costs</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5000</td> 
						<td><span class="zh">　營業成本合計</span><span class="en">　Total operating costs</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OperatingCosts" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,006,576</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OperatingCosts" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">16,873,072</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5900</td> 
						<td><span class="zh">營業毛利（毛損）</span><span class="en">Gross profit (loss) from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GrossProfitLossFromOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,606,371</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GrossProfitLossFromOperations" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,906,256</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5950</td> 
						<td><span class="zh">營業毛利（毛損）淨額</span><span class="en">Gross profit (loss) from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,606,371</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,906,256</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業費用</span><span class="en">Operating expenses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6100</td> 
						<td><span class="zh">　推銷費用</span><span class="en">　Selling expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:SellingExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,814,394</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:SellingExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,417,337</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6200</td> 
						<td><span class="zh">　管理費用</span><span class="en">　Administrative expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdministrativeExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,075,283</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdministrativeExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,141,835</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6300</td> 
						<td><span class="zh">　研究發展費用</span><span class="en">　Research and development expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">913,224</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">808,652</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6450</td> 
						<td><span class="zh">　預期信用減損損失(利益)</span><span class="en">　Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,404</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">384,244</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6000</td> 
						<td><span class="zh">　營業費用合計</span><span class="en">　Total operating expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OperatingExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,821,305</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OperatingExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,752,068</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6900</td> 
						<td><span class="zh">營業利益（損失）</span><span class="en">Net operating income (loss)</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">214,934</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">154,188</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業外收入及支出</span><span class="en">Non-operating income and expenses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　利息收入</span><span class="en">　Interest income</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7100</td> 
						<td><span class="zh">　　利息收入合計</span><span class="en">　　Total interest income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">165,172</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">152,413</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　其他收入</span><span class="en">　Other income</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7010</td> 
						<td><span class="zh">　　其他收入合計</span><span class="en">　　Total other income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">614,737</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">121,116</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　其他利益及損失</span><span class="en">　Other gains and losses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7020</td> 
						<td><span class="zh">　　其他利益及損失淨額</span><span class="en">　　Other gains and losses, net</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,189</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">100,535</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　財務成本</span><span class="en">　Finance costs</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7050</td> 
						<td><span class="zh">　　財務成本淨額</span><span class="en">　　Finance costs, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">256,180</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">163,482</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7000</td> 
						<td><span class="zh">　營業外收入及支出合計</span><span class="en">　Total non-operating income and expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NonoperatingIncomeAndExpenses" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">518,540</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NonoperatingIncomeAndExpenses" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,512</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7900</td> 
						<td><span class="zh">繼續營業單位稅前淨利（淨損）</span><span class="en">Profit (loss) from continuing operations before tax</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">303,606</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">163,700</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">所得稅費用（利益）</span><span class="en">Tax expense (income)</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7950</td> 
						<td><span class="zh">　所得稅費用（利益）合計</span><span class="en">　Total tax expense (income)</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">78,665</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">64,331</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8000</td> 
						<td><span class="zh">繼續營業單位本期淨利（淨損）</span><span class="en">Profit (loss) from continuing operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">224,941</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">99,369</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8200</td> 
						<td><span class="zh">本期淨利（淨損）</span><span class="en">Profit (loss)</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">224,941</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">99,369</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">其他綜合損益(淨額)</span><span class="en">Other comprehensive income</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　不重分類至損益之項目</span><span class="en">　Components of other comprehensive income that will not be reclassified to profit or loss</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8311</td> 
						<td><span class="zh">　　確定福利計畫之再衡量數</span><span class="en">　　Gains (losses) on remeasurements of defined benefit plans</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,674</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">16,135</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8316</td> 
						<td><span class="zh">　　透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益</span><span class="en">　　Unrealised gains (losses) from investments in equity instruments measured at fair value through other comprehensive income</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesFromInvestmentsInEquityInstruments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">745</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesFromInvestmentsInEquityInstruments" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,458</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8349</td> 
						<td><span class="zh">　　與不重分類之項目相關之所得稅</span><span class="en">　　Income tax related to components of other comprehensive income that will not be reclassified to profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">618</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,077</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8310</td> 
						<td><span class="zh">　　不重分類至損益之項目總額</span><span class="en">　　Components of other comprehensive income that will not be reclassified to profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,311</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">14,516</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　後續可能重分類至損益之項目</span><span class="en">　Components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8361</td> 
						<td><span class="zh">　　國外營運機構財務報表換算之兌換差額</span><span class="en">　　Exchange differences on translation</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">496,704</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">766,251</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8399</td> 
						<td><span class="zh">　　與可能重分類之項目相關之所得稅</span><span class="en">　　Income tax related to components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80,591</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">138,888</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8360</td> 
						<td><span class="zh">　　後續可能重分類至損益之項目總額</span><span class="en">　　Components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">416,113</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">627,363</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8300</td> 
						<td><span class="zh">　其他綜合損益（淨額）</span><span class="en">　Total other comprehensive income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">419,424</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">641,879</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8500</td> 
						<td><span class="zh">本期綜合損益總額</span><span class="en">Total comprehensive income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">644,365</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">542,510</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">淨利（損）歸屬於：</span><span class="en">Profit (loss), attributable to:</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8610</td> 
						<td><span class="zh">　母公司業主（淨利／損）</span><span class="en">　Profit (loss), attributable to owners of parent</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">429,024</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">38,148</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8620</td> 
						<td><span class="zh">　非控制權益（淨利／損）</span><span class="en">　Profit (loss), attributable to non-controlling interests</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">204,083</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">61,221</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">綜合損益總額歸屬於：</span><span class="en">Comprehensive income attributable to:</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8710</td> 
						<td><span class="zh">　母公司業主（綜合損益）</span><span class="en">　Comprehensive income, attributable to owners of parent</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">754,701</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">531,277</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8720</td> 
						<td><span class="zh">　非控制權益（綜合損益）</span><span class="en">　Comprehensive income, attributable to non-controlling interests</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">110,336</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">11,233</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">基本每股盈餘</span><span class="en">Basic earnings per share</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9750</td> 
						<td><span class="zh">　基本每股盈餘合計</span><span class="en">　Total basic earnings per share</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">1.42</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">0.13</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">稀釋每股盈餘</span><span class="en">Diluted earnings per share</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9850</td> 
						<td><span class="zh">　稀釋每股盈餘合計</span><span class="en">　Total diluted earnings per share</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">1.42</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">0.13</ix:nonFraction> </pre></td>
					</tr> 
				</table> 
				<br /> 
			<!-- 現金流量表 -->
			<div id="StatementsOfCashFlows"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">現金流量表</span><span class="en">Statements of Cash Flows</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2022年1月1日至12月31日</span><span class="en">2022/1/1To12/31</span></th> 
						<th><span class="zh">2021年1月1日至12月31日</span><span class="en">2021/1/1To12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業活動之現金流量－間接法</span><span class="en">Cash flows from (used in) operating activities, indirect method</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A00010</td> 
						<td><span class="zh">　繼續營業單位稅前淨利（淨損）</span><span class="en">　Profit (loss) from continuing operations before tax</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">303,606</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">163,700</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A10000</td> 
						<td><span class="zh">　本期稅前淨利（淨損）</span><span class="en">　Profit (loss) before tax</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">303,606</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProfitLossBeforeTax" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">163,700</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　調整項目</span><span class="en">　Adjustments</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　收益費損項目</span><span class="en">　　Adjustments to reconcile profit (loss)</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20100</td> 
						<td><span class="zh">　　　折舊費用</span><span class="en">　　　Depreciation expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,124,453</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">959,825</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20200</td> 
						<td><span class="zh">　　　攤銷費用</span><span class="en">　　　Amortization expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">82,127</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80,400</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20300</td> 
						<td><span class="zh">　　　預期信用減損損失（利益）數／呆帳費用提列（轉列收入）數</span><span class="en">　　　Expected credit loss (gain) / Provision (reversal of provision) for bad debt expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProvisionReversalOfProvisionForBadDebtExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,404</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProvisionReversalOfProvisionForBadDebtExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">384,243</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20400</td> 
						<td><span class="zh">　　　透過損益按公允價值衡量金融資產及負債之淨損失（利益）</span><span class="en">　　　Net loss (gain) on financial assets or liabilities at fair value through profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:NetLossGainOnFinancialAssetsOrLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">284</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:NetLossGainOnFinancialAssetsOrLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,901</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20900</td> 
						<td><span class="zh">　　　利息費用</span><span class="en">　　　Interest expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForInterestExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">256,180</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForInterestExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">163,482</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A21200</td> 
						<td><span class="zh">　　　利息收入</span><span class="en">　　　Interest income</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForInterestIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">165,172</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForInterestIncome" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">152,413</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A21900</td> 
						<td><span class="zh">　　　股份基礎給付酬勞成本</span><span class="en">　　　Share-based payments</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,349</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A22500</td> 
						<td><span class="zh">　　　處分及報廢不動產、廠房及設備損失（利益）</span><span class="en">　　　Loss (gain) on disposal of property, plan and equipment</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,384</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,439</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A22800</td> 
						<td><span class="zh">　　　處分無形資產損失（利益）</span><span class="en">　　　Loss (gain) on disposal of intangible assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:LossGainOnDisposalOfIntangibleAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">157</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:LossGainOnDisposalOfIntangibleAssets" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,082</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20010</td> 
						<td><span class="zh">　　　收益費損項目合計</span><span class="en">　　　Total adjustments to reconcile profit (loss)</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:AdjustmentsToReconcileProfitLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,318,817</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:AdjustmentsToReconcileProfitLoss" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,441,266</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　與營業活動相關之資產／負債變動數</span><span class="en">　　Changes in operating assets and liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　與營業活動相關之資產之淨變動</span><span class="en">　　　Changes in operating assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31125</td> 
						<td><span class="zh">　　　　合約資產（增加）減少</span><span class="en">　　　　Decrease (increase) in contract assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInContractAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,627</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInContractAssets" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,120</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31130</td> 
						<td><span class="zh">　　　　應收票據（增加）減少</span><span class="en">　　　　Decrease (increase) in notes receivable</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInNotesReceivable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">8,985</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInNotesReceivable" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">11,193</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31150</td> 
						<td><span class="zh">　　　　應收帳款（增加）減少</span><span class="en">　　　　Decrease (increase) in accounts receivable</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInAccountsReceivable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,193,762</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInAccountsReceivable" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">897,045</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31180</td> 
						<td><span class="zh">　　　　其他應收款（增加）減少</span><span class="en">　　　　Decrease (increase) in other receivable</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInOtherReceivables" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">674,469</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInOtherReceivables" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">128,730</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31200</td> 
						<td><span class="zh">　　　　存貨（增加）減少</span><span class="en">　　　　Adjustments for decrease (increase) in inventories</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">134,180</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,728,413</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31230</td> 
						<td><span class="zh">　　　　預付款項（增加）減少</span><span class="en">　　　　Decrease (increase) in prepayments</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInPrepayments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">17,826</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInPrepayments" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">84,958</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31240</td> 
						<td><span class="zh">　　　　其他流動資產（增加）減少</span><span class="en">　　　　Adjustments for decrease (increase) in other current assets</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">58,483</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">43,408</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31990</td> 
						<td><span class="zh">　　　　其他營業資產（增加）減少</span><span class="en">　　　　Decrease (increase) in other operating assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInOtherOperatingAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">286,748</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInOtherOperatingAssets" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">156,319</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31000</td> 
						<td><span class="zh">　　　　與營業活動相關之資產之淨變動合計</span><span class="en">　　　　Total changes in operating assets</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,787,330</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssets" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,090,186</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　與營業活動相關之負債之淨變動</span><span class="en">　　　Changes in operating liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32125</td> 
						<td><span class="zh">　　　　合約負債增加（減少）</span><span class="en">　　　　Increase (decrease) in contract liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInContractLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">27,237</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInContractLiabilities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">228</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32130</td> 
						<td><span class="zh">　　　　應付票據增加（減少）</span><span class="en">　　　　Increase (decrease) in notes payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInNotesPayable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">66,489</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInNotesPayable" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">47,008</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32150</td> 
						<td><span class="zh">　　　　應付帳款增加（減少）</span><span class="en">　　　　Increase (decrease) in accounts payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccountsPayable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">111,908</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccountsPayable" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">145,672</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32180</td> 
						<td><span class="zh">　　　　其他應付款增加（減少）</span><span class="en">　　　　Increase (decrease) in other payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherPayables" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">505,021</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherPayables" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">357,825</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32200</td> 
						<td><span class="zh">　　　　負債準備增加（減少）</span><span class="en">　　　　Increase (decrease) in provisions</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInProvisions" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">56,862</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInProvisions" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">86,270</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32230</td> 
						<td><span class="zh">　　　　其他流動負債增加（減少）</span><span class="en">　　　　Adjustments for increase (decrease) in other current liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">57,401</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">52,413</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32240</td> 
						<td><span class="zh">　　　　淨確定福利負債增加(減少)</span><span class="en">　　　　Increase (decrease) in net defined benefit liability</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccruedPensionLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,065</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccruedPensionLiabilities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,698</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32990</td> 
						<td><span class="zh">　　　　其他營業負債增加（減少）</span><span class="en">　　　　Increase (decrease) in other operating liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherOperatingLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">220,066</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherOperatingLiabilities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">52,311</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32000</td> 
						<td><span class="zh">　　　　與營業活動相關之負債之淨變動合計</span><span class="en">　　　　Total changes in operating liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">804,393</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingLiabilities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">253,443</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A30000</td> 
						<td><span class="zh">　　　與營業活動相關之資產及負債之淨變動合計</span><span class="en">　　　Total changes in operating assets and liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssetsAndLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">982,937</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssetsAndLiabilities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,836,743</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20000</td> 
						<td><span class="zh">　　調整項目合計</span><span class="en">　　Total adjustments</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:Adjustments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">335,880</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:Adjustments" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,395,477</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33000</td> 
						<td><span class="zh">　營運產生之現金流入（流出）</span><span class="en">　Cash inflow (outflow) generated from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">639,486</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,231,777</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33100</td> 
						<td><span class="zh">　收取之利息</span><span class="en">　Interest received</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">165,172</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">152,413</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33300</td> 
						<td><span class="zh">　支付之利息</span><span class="en">　Interest paid</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">222,813</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">115,353</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33500</td> 
						<td><span class="zh">　退還（支付）之所得稅</span><span class="en">　Income taxes refund (paid)</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">189,392</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">342,309</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">AAAA</td> 
						<td><span class="zh">營業活動之淨現金流入（流出）</span><span class="en">Net cash flows from (used in) operating activities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">392,453</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,537,026</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">投資活動之現金流量</span><span class="en">Cash flows from (used in) investing activities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02200</td> 
						<td><span class="zh">　對子公司之收購（扣除所取得之現金）</span><span class="en">　Net cash flow from acquisition of subsidiaries</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">251,440</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02700</td> 
						<td><span class="zh">　取得不動產、廠房及設備</span><span class="en">　Acquisition of property, plant and equipment</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">407,775</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">692,042</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02800</td> 
						<td><span class="zh">　處分不動產、廠房及設備</span><span class="en">　Proceeds from disposal of property, plant and equipment</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">24,017</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,290</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B04500</td> 
						<td><span class="zh">　取得無形資產</span><span class="en">　Acquisition of intangible assets</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">33,078</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">68,126</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B04600</td> 
						<td><span class="zh">　處分無形資產</span><span class="en">　Proceeds from disposal of intangible assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,485</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B05500</td> 
						<td><span class="zh">　處分投資性不動產</span><span class="en">　Proceeds from disposal of investment properties</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfInvestmentProperty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">548</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfInvestmentProperty" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">617</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">BBBB</td> 
						<td><span class="zh">　投資活動之淨現金流入（流出）</span><span class="en">　Net cash flows from (used in) investing activities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:NetCashFlowsFromUsedInInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">667,728</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:NetCashFlowsFromUsedInInvestingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">721,776</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">籌資活動之現金流量</span><span class="en">Cash flows from (used in) financing activities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C00100</td> 
						<td><span class="zh">　短期借款增加</span><span class="en">　Increase in short-term loans</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseInShortTermLoans" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">47,931,445</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseInShortTermLoans" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,916,719</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C00200</td> 
						<td><span class="zh">　短期借款減少</span><span class="en">　Decrease in short-term loans</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseInShortTermLoans" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">43,254,385</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseInShortTermLoans" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">10,574,071</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C00600</td> 
						<td><span class="zh">　應付短期票券減少</span><span class="en">　Decrease in short-term notes and bills payable</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseInShortTermNotesAndBillsPayable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,229,020</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseInShortTermNotesAndBillsPayable" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,689,358</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C01600</td> 
						<td><span class="zh">　舉借長期借款</span><span class="en">　Proceeds from long-term debt</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromLongTermDebt" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,610,985</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromLongTermDebt" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">593,965</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C01700</td> 
						<td><span class="zh">　償還長期借款</span><span class="en">　Repayments of long-term debt</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:RepaymentsOfLongTermDebt" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,338,156</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:RepaymentsOfLongTermDebt" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">716,018</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04020</td> 
						<td><span class="zh">　租賃本金償還</span><span class="en">　Payments of lease liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">582,516</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">564,411</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04500</td> 
						<td><span class="zh">　發放現金股利</span><span class="en">　Cash dividends paid</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">151,294</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">338,899</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04800</td> 
						<td><span class="zh">　員工執行認股權</span><span class="en">　Exercise of employee share options</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ExerciseOfEmployeeShareOptions" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">20,260</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ExerciseOfEmployeeShareOptions" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C05800</td> 
						<td><span class="zh">　非控制權益變動</span><span class="en">　Change in non-controlling interests</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangeInNoncontrollingInterests" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">160,795</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangeInNoncontrollingInterests" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">23,481</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">CCCC</td> 
						<td><span class="zh">　籌資活動之淨現金流入（流出）</span><span class="en">　Net cash flows from (used in) financing activities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashFlowsFromUsedInFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">846,524</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashFlowsFromUsedInFinancingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,983,162</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">DDDD</td> 
						<td><span class="zh">匯率變動對現金及約當現金之影響</span><span class="en">Effect of exchange rate changes on cash and cash equivalents</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">345,228</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">402,084</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">EEEE</td> 
						<td><span class="zh">本期現金及約當現金增加（減少）數</span><span class="en">Net increase (decrease) in cash and cash equivalents</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">916,477</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">677,724</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00100</td> 
						<td><span class="zh">期初現金及約當現金餘額</span><span class="en">Cash and cash equivalents at beginning of period</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtBeginningOfPeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,615,077</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtBeginningOfPeriod" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,292,801</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00200</td> 
						<td><span class="zh">期末現金及約當現金餘額</span><span class="en">Cash and cash equivalents at end of period</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtEndOfPeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,531,554</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtEndOfPeriod" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,615,077</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00210</td> 
						<td><span class="zh">　資產負債表帳列之現金及約當現金</span><span class="en">　Cash and cash equivalents reported in the statement of financial position</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,531,554</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,615,077</ix:nonFraction> </pre></td>
					</tr> 

				</table> 
				<br /> 
			<!-- 當期權益變動表 -->
			<div id="StatementsOfChangeInEquity"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:150%"> 
					<tr> 
						<th colspan="32"> 
							<span class="zh">當期權益變動表</span><span class="en">Statements of Change in Equity</span> 
						</th> 
					</tr> 
					<tr> 
						<th colspan='2' rowspan='2'></th> 
						<th>3110</th>
						<th>3100</th>
						<th>3200</th>
						<th>3310</th>
						<th>3320</th>
						<th>3350</th>
						<th>3300</th>
						<th>3410</th>
						<th>3420</th>
						<th>3400</th>
						<th>3500</th>
						<th>31XX</th>
						<th>36XX</th>
						<th>3XXX</th>
					</tr> 
					<tr> 
						<th> 
							<span class="zh">普通股股本</span> 
							<span class="en">　　　　　Ordinary share</span> 
						</th>
						<th> 
							<span class="zh">股本合計</span> 
							<span class="en">　　　　Total share capital</span> 
						</th>
						<th> 
							<span class="zh">資本公積</span> 
							<span class="en">　　　　Capital surplus</span> 
						</th>
						<th> 
							<span class="zh">法定盈餘公積</span> 
							<span class="en">　　　　　Legal reserve</span> 
						</th>
						<th> 
							<span class="zh">特別盈餘公積</span> 
							<span class="en">　　　　　Special reserve</span> 
						</th>
						<th> 
							<span class="zh">未分配盈餘（或待彌補虧損）</span> 
							<span class="en">　　　　　Unappropriated retained earnings (accumulated deficit)</span> 
						</th>
						<th> 
							<span class="zh">保留盈餘合計</span> 
							<span class="en">　　　　Total retained earnings</span> 
						</th>
						<th> 
							<span class="zh">國外營運機構財務報表換算之兌換差額</span> 
							<span class="en">　　　　　Exchange differences on translation of foreign financial statements</span> 
						</th>
						<th> 
							<span class="zh">透過其他綜合損益按公允價值衡量之金融資產未實現評價(損)益</span> 
							<span class="en">　　　　　Unrealised gains (losses) on financial assets measured at fair value through other comprehensive income</span> 
						</th>
						<th> 
							<span class="zh">其他權益項目合計</span> 
							<span class="en">　　　　Total other equity interest</span> 
						</th>
						<th> 
							<span class="zh">庫藏股票</span> 
							<span class="en">　　　　Treasury shares</span> 
						</th>
						<th> 
							<span class="zh">歸屬於母公司業主之權益總計</span> 
							<span class="en">　　　Total equity attributable to owners of parent</span> 
						</th>
						<th> 
							<span class="zh">非控制權益</span> 
							<span class="en">　　　Non-controlling interests</span> 
						</th>
						<th> 
							<span class="zh">權益總額</span> 
							<span class="en">　　Total equity</span> 
						</th>
					</tr> 
					<tr> 
						<td>A1</td> 
						<td> 
							<span class="zh">期初餘額</span> 
							<span class="en">　Equity at beginning of period</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,036,166</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,036,166</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">59,979</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,509,898</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,385,492</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,504,183</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,399,573</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,942,671</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">662</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,942,009</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">73,872</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,479,837</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">901,347</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,381,184</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B1</td> 
						<td> 
							<span class="zh">提列法定盈餘公積</span> 
							<span class="en">　　Legal reserve appropriated</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,524</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,524</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B3</td> 
						<td> 
							<span class="zh">提列特別盈餘公積</span> 
							<span class="en">　　Special reserve appropriated</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">556,517</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">556,517</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B5</td> 
						<td> 
							<span class="zh">普通股現金股利</span> 
							<span class="en">　　Cash dividends of ordinary share</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">151,294</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">151,294</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">151,294</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">151,294</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>D1</td> 
						<td> 
							<span class="zh">本期淨利（淨損）</span> 
							<span class="en">　Profit (loss)</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">429,024</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">429,024</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">429,024</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">204,083</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">224,941</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D3</td> 
						<td> 
							<span class="zh">本期其他綜合損益</span> 
							<span class="en">　Other comprehensive income</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,739</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,739</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">322,366</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">428</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">321,938</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">325,677</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">93,747</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">419,424</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D5</td> 
						<td> 
							<span class="zh">本期綜合損益總額</span> 
							<span class="en">　Total comprehensive income</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">432,763</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">432,763</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">322,366</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">428</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">321,938</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">754,701</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">110,336</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">644,365</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>M5</td> 
						<td> 
							<span class="zh">實際取得或處分子公司股權價格與帳面價值差額</span> 
							<span class="en">　Difference between consideration and carrying amount of subsidiaries acquired or disposed</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">371,467</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">371,467</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">622,907</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">251,440</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>N1</td> 
						<td> 
							<span class="zh">股份基礎給付</span> 
							<span class="en">　Share-based payments</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">20,260</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">20,260</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">20,260</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>O1</td> 
						<td> 
							<span class="zh">非控制權益增減</span> 
							<span class="en">　Changes in non-controlling interests</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">160,795</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">160,795</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>Y1</td> 
						<td> 
							<span class="zh">權益增加(減少)總額</span> 
							<span class="en">　Total increase (decrease) in equity</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">371,467</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,524</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">556,517</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">277,572</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">281,469</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">322,366</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">428</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">321,938</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">20,260</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">995,134</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">894,038</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">101,096</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Z1</td> 
						<td> 
							<span class="zh">期末餘額</span> 
							<span class="en">　Equity at end of period</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,036,166</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,036,166</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">431,446</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,512,422</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,942,009</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,226,611</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,681,042</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,620,305</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">234</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,620,071</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">53,612</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,309</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,482,280</ix:nonFraction> </pre></td>
					</tr>
				</table> 
				<br /> 
			<!-- 去年同期權益變動表 -->
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:150%"> 
					<tr> 
						<th colspan="32"> 
							<span class="zh">去年同期權益變動表</span><span class="en"> Last year's Statements of Change in Equity </span> 
						</th> 
					</tr> 
					<tr> 
						<th colspan='2' rowspan='2'></th> 
						<th>3110</th>
						<th>3100</th>
						<th>3200</th>
						<th>3310</th>
						<th>3320</th>
						<th>3350</th>
						<th>3300</th>
						<th>3410</th>
						<th>3420</th>
						<th>3400</th>
						<th>3500</th>
						<th>31XX</th>
						<th>36XX</th>
						<th>3XXX</th>
					</tr> 
					<tr> 
						<th> 
							<span class="zh">普通股股本</span> 
							<span class="en">　　　　　Ordinary share</span> 
						</th>
						<th> 
							<span class="zh">股本合計</span> 
							<span class="en">　　　　Total share capital</span> 
						</th>
						<th> 
							<span class="zh">資本公積</span> 
							<span class="en">　　　　Capital surplus</span> 
						</th>
						<th> 
							<span class="zh">法定盈餘公積</span> 
							<span class="en">　　　　　Legal reserve</span> 
						</th>
						<th> 
							<span class="zh">特別盈餘公積</span> 
							<span class="en">　　　　　Special reserve</span> 
						</th>
						<th> 
							<span class="zh">未分配盈餘（或待彌補虧損）</span> 
							<span class="en">　　　　　Unappropriated retained earnings (accumulated deficit)</span> 
						</th>
						<th> 
							<span class="zh">保留盈餘合計</span> 
							<span class="en">　　　　Total retained earnings</span> 
						</th>
						<th> 
							<span class="zh">國外營運機構財務報表換算之兌換差額</span> 
							<span class="en">　　　　　Exchange differences on translation of foreign financial statements</span> 
						</th>
						<th> 
							<span class="zh">透過其他綜合損益按公允價值衡量之金融資產未實現評價(損)益</span> 
							<span class="en">　　　　　Unrealised gains (losses) on financial assets measured at fair value through other comprehensive income</span> 
						</th>
						<th> 
							<span class="zh">其他權益項目合計</span> 
							<span class="en">　　　　Total other equity interest</span> 
						</th>
						<th> 
							<span class="zh">庫藏股票</span> 
							<span class="en">　　　　Treasury shares</span> 
						</th>
						<th> 
							<span class="zh">歸屬於母公司業主之權益總計</span> 
							<span class="en">　　　Total equity attributable to owners of parent</span> 
						</th>
						<th> 
							<span class="zh">非控制權益</span> 
							<span class="en">　　　Non-controlling interests</span> 
						</th>
						<th> 
							<span class="zh">權益總額</span> 
							<span class="en">　　Total equity</span> 
						</th>
					</tr> 
					<tr> 
						<td>A1</td> 
						<td> 
							<span class="zh">期初餘額</span> 
							<span class="en">　Equity at beginning of period</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,036,166</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,036,166</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">55,630</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,441,895</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,370,838</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,900,499</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,713,232</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,387,118</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,626</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,385,492</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">73,872</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,345,664</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">936,061</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,281,725</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B1</td> 
						<td> 
							<span class="zh">提列法定盈餘公積</span> 
							<span class="en">　　Legal reserve appropriated</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20210101To20211231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">68,003</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">68,003</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B3</td> 
						<td> 
							<span class="zh">提列特別盈餘公積</span> 
							<span class="en">　　Special reserve appropriated</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20210101To20211231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,654</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">14,654</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B5</td> 
						<td> 
							<span class="zh">普通股現金股利</span> 
							<span class="en">　　Cash dividends of ordinary share</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">338,899</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">338,899</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">338,899</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">338,899</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>D1</td> 
						<td> 
							<span class="zh">本期淨利（淨損）</span> 
							<span class="en">　Profit (loss)</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">38,148</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">38,148</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">38,148</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">61,221</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">99,369</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D3</td> 
						<td> 
							<span class="zh">本期其他綜合損益</span> 
							<span class="en">　Other comprehensive income</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,908</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,908</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">555,553</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">964</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">556,517</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">569,425</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">72,454</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">641,879</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>D5</td> 
						<td> 
							<span class="zh">本期綜合損益總額</span> 
							<span class="en">　Total comprehensive income</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,240</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,240</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">555,553</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">964</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">556,517</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">531,277</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">11,233</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">542,510</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>N1</td> 
						<td> 
							<span class="zh">股份基礎給付</span> 
							<span class="en">　Share-based payments</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,349</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,349</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,349</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>O1</td> 
						<td> 
							<span class="zh">非控制權益增減</span> 
							<span class="en">　Changes in non-controlling interests</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20210101To20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">23,481</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">23,481</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>Y1</td> 
						<td> 
							<span class="zh">權益增加(減少)總額</span> 
							<span class="en">　Total increase (decrease) in equity</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,349</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">68,003</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,654</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">396,316</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">313,659</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">555,553</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">964</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">556,517</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">865,827</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">34,714</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">900,541</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>Z1</td> 
						<td> 
							<span class="zh">期末餘額</span> 
							<span class="en">　Equity at end of period</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,036,166</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,036,166</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">59,979</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,509,898</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,385,492</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,504,183</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,399,573</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,942,671</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">662</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,942,009</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">73,872</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,479,837</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">901,347</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,381,184</ix:nonFraction> </pre></td>
					</tr>

				</table> 
				<br /> 
			<!-- 會計師查核報告 -->	
			<div id="ReportOfIndependentAuditors"></div> 
			<span class="zh">
			<div class="rptidx">單位：新臺幣仟元</div> 
				<table> 
					<tr>
						<th colspan="3">會計師查核（核閱）報告</th> 
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 會計師事務所名稱</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AccountantName" contextRef="AsOf20230314" xml:lang="zh" escape="true">安永聯合會計師事務所</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簽證會計師名稱 1</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AssuranceAccountantName1" contextRef="AsOf20230314" xml:lang="zh" escape="true">陳明宏</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簽證會計師名稱 2</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AssuranceAccountantName2" contextRef="AsOf20230314" xml:lang="zh" escape="true">黃宇廷</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 核閱或查核日期</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:ReviewAuditDate" contextRef="AsOf20230314" xml:lang="zh" escape="true">2023-03-14</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 報告類型</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　　 查核報告</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AuditReport" contextRef="AsOf20230314" xml:lang="zh" escape="true">Y</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 核閱或查核報告類型</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　　 無保留意見/結論</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:UnqualifiedOpinionAbstract" contextRef="AsOf20230314" xml:lang="zh" escape="true">Y</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 報告類型細分</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簡述強調事項內容</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簡述其他事項內容</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 會計師查核(核閱)報告內容</th> 
						<td colspan="2"><pre class="note"><ix:nonNumeric name="tifrs-ar:AccountantsReportBody" contextRef="AsOf20230314" xml:lang="zh" escape="true">　　　　　　　　　　　　　　　　　　　　　　　會計師查核報告　　　　　　　　　　　　　　　　　　　　　　　

喬山健康科技股份有限公司　公鑒：

查核意見

　　喬山健康科技股份有限公司及其子公司民國一一一年十二月三十一日及民國一一０年十二月三十一日之合併資產負債
表，暨民國一一一年一月一日至十二月三十一日及民國一一０年一月一日至十二月三十一日之合併綜合損益表、合併權益
變動表、合併現金流量表，以及合併財務報表附註(包括重大會計政策彙總)，業經本會計師查核竣事。

　　依本會計師之意見，上開合併財務報表在所有重大方面係依照證券發行人財務報告編製準則暨經金融監督管理委員會
認可並發布生效之國際財務報導準則、國際會計準則、國際財務報導解釋及解釋公告編製，足以允當表達喬山健康科技股
份有限公司及其子公司民國一一一年十二月三十一日及民國一一０年十二月三十一日之合併財務狀況，暨民國一一一年一
月一日至十二月三十一日及民國一一０年一月一日至十二月三十一日之合併財務績效及合併現金流量。

查核意見之基礎

　　本會計師係依照會計師查核簽證財務報表規則及審計準則執行查核工作。本會計師於該等準則下之責任將於會計師查
核合併財務報表之責任段進一步說明。本會計師所隸屬事務所受獨立性規範之人員已依會計師職業道德規範，與喬山健康
科技股份有限公司及其子公司保持超然獨立，並履行該規範之其他責任。本會計師相信已取得足夠及適切之查核證據，以
作為表示查核意見之基礎。

關鍵查核事項

　　關鍵查核事項係指依本會計師之專業判斷，對喬山健康科技股份有限公司及其子公司民國一一一年度合併財務報表之
查核最為重要之事項。該等事項已於查核合併財務報表整體及形成查核意見之過程中予以因應，本會計師並不對該等事項
單獨表示意見。

應收帳款之備抵損失

　　截至民國一一一年十二月三十一日，喬山健康科技股份有限公司及其子公司應收帳款及備抵損失之帳面金額分別為新
台幣9,234,948仟元及542,532仟元，應收帳款淨額占合併資產總額23%，對於喬山健康科技股份有限公司及其子公司係屬
重大。由於應收帳款之備抵損失金額係以存續期間之預期信用損失衡量，衡量過程須對應收帳款適當區分群組，並判斷分
析衡量過程相關假設之運用，包括適當之帳齡區間及各帳齡區間損失率之考量，基於衡量預期信用損失涉及判斷、分析及
估計，且衡量結果影響應收帳款淨額，因此本會計師辨認為關鍵查核事項。

　　本會計師查核程序包括(但不限於)，評估管理階層針對應收帳款管理所建立之內部控制的有效性，包括執行簡易測試
及瞭解管理階層如何評估應收款帳之預期信用損失及區分風險群組和各群組之預期損失率、抽選樣本執行應收帳款函證、
分析前後期應收帳款變動及週轉率變動的趨勢、檢視應收帳款期後收款情形以評估可回收性及針對較長天期之應收帳款評
估個別應收帳款減損之合理性。

　　本會計師亦考量合併財務報表附註五及附註六中有關應收帳款揭露的適當性。

存貨評價

　　截至民國一一一年十二月三十一日，喬山健康科技股份有限公司及其子公司存貨淨額為新台幣11,808,413仟元，佔合
併資產總額30%，由於產品受到市場需求波動及技術快速變化而可能導致呆滯或過時之損失，存貨之備抵跌價估計涉及管
理階層重大判斷，故本會計師決定為關鍵查核事項。

　　本會計師的查核程序包括(但不限於)評估管理階層針對存貨所建立之內部控制之有效性，包括執行簡易測試及瞭解管
理階層評估呆滯及過時存貨之會計政策的適當性、抽核測試存貨庫齡區間之正確性以判斷存貨庫齡表是否合理、選擇重大
庫存地點執行觀察存貨盤點程序，此外，本會計師亦取得當年度進銷存明細表，抽核測試存貨之進貨和銷貨相關憑證，並
驗算存貨單位成本，評估管理階層對存貨評價所採用之淨變現價值。

　　本會計師亦考量與存貨評價有關揭露之適當性，請參閱合併財務報表附註五及六。

商譽減損

　　截至民國一一一年十二月三十一日，喬山健康科技股份有限公司及其子公司商譽總計新台幣2,242,784仟元，佔合併
資產總額6%。該公司依據國際財務報導準則之規範，針對相關現金產生單位進行減損測試。該公司因公允價值無法可靠衡
量﹐而以使用價值衡量可回收金額。由於商譽帳面價值對喬山健康科技股份有限公司及其子公司係屬重大、使用價值之評
估較為複雜﹐且管理階層對於現金流量之預測所作之各種假設涉及管理階層重大判斷。因此，本會計師決定為關鍵查核事
項。

　　本會計師查核程序包括(但不限於)分析管理階層評估使用價值之方法與假設；採用內部專家協助本會計師，評估管理
階層關於成長率、折現率及毛利率等關鍵假設之合理性，包含參考與現金產生單位類似規模之公司，評估折現率組成項目
之權益資金成本、公司特定風險溢酬及市場風險溢酬等關鍵輸入值之合理性；訪談管理階層並分析財務預測中之毛利率、
營收成長率、整體市場及經濟情況預測之合理性；比較當期預測性財務資訊與截至目前已達成果，分析公司歷史資料與績
效，以評估現金流量預測之合理性。

　　本會計師亦考量財務報表附註五及六有關減損測試結果及假設敏感性揭露之適當性。

管理階層與治理單位對合併財務報表之責任

　　管理階層之責任係依照證券發行人財務報告編製準則暨經金融監督管理委員會認可並發布生效之國際財務報導準則、
國際會計準則、國際財務報導解釋及解釋公告編製允當表達之合併財務報表，且維持與合併財務報表編製有關之必要內部
控制，以確保合併財務報表未存有導因於舞弊或錯誤之重大不實表達。

　　於編製合併財務報表時，管理階層之責任亦包括評估喬山健康科技股份有限公司及其子公司繼續經營之能力、相關事
項之揭露，以及繼續經營會計基礎之採用，除非管理階層意圖清算喬山健康科技股份有限公司及其子公司或停止營業，或
除清算或停業外別無實際可行之其他方案。

　　喬山健康科技股份有限公司及其子公司之治理單位(含審計委員會)負有監督財務報導流程之責任。

會計師查核合併財務報表之責任

　　本會計師查核合併財務報表之目的，係對合併財務報表整體是否存有導因於舞弊或錯誤之重大不實表達取得合理確信
，並出具查核報告。合理確信係高度確信，惟依照審計準則執行之查核工作無法保證必能偵出合併財務報表存有之重大不
實表達。不實表達可能導因於舞弊或錯誤。如不實表達之個別金額或彙總數可合理預期將影響個體財務報表使用者所作之
經濟決策，則被認為具有重大性。

　　本會計師依照審計準則查核時，運用專業判斷及專業之懷疑。本會計師亦執行下列工作：

　　1.辨認並評估合併財務報表導因於舞弊或錯誤之重大不實表達風險；對所評估之風險設計及執行適當之因應對策；並
　　　取得足夠及適切之查核證據以作為查核意見之基礎。因舞弊可能涉及共謀、偽造、故意遺漏、不實聲明或踰越內部
　　　控制，故未偵出導因於舞弊之重大不實表達之風險高於導因於錯誤者。

　　2.對與查核攸關之內部控制取得必要之瞭解，以設計當時情況下適當之查核程序，惟其目的非對喬山健康科技股份有
　　　限公司及其子公司內部控制之有效性表示意見。

　　3.評估管理階層所採用會計政策之適當性，及其所作會計估計與相關揭露之合理性。

　　4.依據所取得之查核證據，對管理階層採用繼續經營會計基礎之適當性，以及使喬山健康科技股份有限公司及其子公
　　　司繼續經營之能力可能產生重大疑慮之事件或情況是否存在重大不確定性，作出結論。本會計師若認為該等事件或
　　　情況存在重大不確定性，則須於查核報告中提醒合併財務報表使用者注意合併財務報表之相關揭露，或於該等揭露
　　　係屬不適當時修正查核意見。本會計師之結論係以截至查核報告日所取得之查核證據為基礎。惟未來事件或情況可
　　　能導致喬山健康科技股份有限公司及其子公司不再具有繼續經營之能力。

　　5.評估合併財務報表(包括相關附註)之整體表達、結構及內容，以及合併財務報表是否允當表達相關交易及事件。

　　6.對於集團內組成個體之財務資訊取得足夠及適切之查核證據，以對合併財務報表表示意見。本會計師負責集團查核
　　　案件之指導、監督及執行，並負責形成集團查核意見。

　　本會計師與治理單位溝通之事項，包括所規劃之查核範圍及時間，以及重大查核發現(包括於查核過程中所辨認之內
部控制顯著缺失)。

　　本會計師亦向治理單位提供本會計師所隸屬事務所受獨立性規範之人員已遵循會計師職業道德規範中有關獨立性之聲
明，並與治理單位溝通所有可能被認為會影響會計師獨立性之關係及其他事項(包括相關防護措施)。

　　本會計師從與治理單位溝通之事項中，決定對喬山健康科技股份有限公司及其子公司民國一一一年度合併財務報表查
核之關鍵查核事項。本會計師於查核報告中敘明該等事項，除非法令不允許公開揭露特定事項，或在極罕見情況下，本會
計師決定不於查核報告中溝通特定事項，因可合理預期此溝通所產生之負面影響大於所增進之公眾利益。

其他

　　喬山健康科技股份有限公司已編製民國一一一年度及一一０年度之個體財務報告，並經本會計師出具無保留意見之查
核報告在案，備供參考。



　　　　　　　　　　　　　　　　　　　　　　　　　　　　安 永 聯 合 會 計 師 事 務 所
　　　　　　　　　　　　　　　　　　　　　　　　　　　　主管機關核准辦理公開發行財務報告
　　　　　　　　　　　　　　　　　　　　　　　　　　　　查核簽證文號：金管證審字第1060027042號
　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　金管證審字第1080326041號
             

　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　陳  明  宏

　　　　　　　　　　　　　　　　　　　　　　　　　　　　會計師：

　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　黃  宇  廷


　　　　　　　　　　　　　　　　　　　　　　　　　　　　中華民國一一二年三月十四日
</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之子公司期末資產總額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfAssetsOfSubsidiariesWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之子公司營業收入淨額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:TotalYearToDateRevenuesOfSubsidiariesWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之採用權益法之投資期末餘額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfInvestmentsAccountedForUsingEquityMethodWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之採用權益法之投資當期認列關聯企業及合資損益之份額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:ShareOfProfitLossForTheQuarterOfAssociatesAndJointVenturesAccountedForUsingEquityMethodWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之子公司期末資產總額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfAssetsOfSubsidiariesWhoseFinancialStatementsWereOnUnauditedOrUnreviewed" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之子公司綜合損益金額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:YearToDateComprehensiveIncomeOfSubsidiariesWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之採用權益法之投資期末餘額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfInvestmentsAccountedForUsingEquityMethodWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之採用權益法之投資當期認列關聯企業及合資損益之份額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:ShareOfYearToDateProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
				</table>
			</span>

			<br />
			<span class="zh">
			<div class="title">財務報表附註</div>
			<div id="HistoryAndOrganization">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">公司沿革及業務範圍</th>
					</tr> 
					<tr>
						<td>　 公司沿革及業務範圍</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:HistoryAndOrganization" contextRef="From20220101To20221231" escape="true">
喬山健康科技股份有限公司(以下簡稱本公司)成立於民國六十四年十月，主要經營健身器材、心肺復甦健身機、重量訓練
機、電動按摩椅及相關馬達、儀錶及電子控制板之製造買賣及內外銷業務。民國八十九年七月為因應未來籌資管道多元化
需求，乃向證券主管機關提出申請並經核准完成股票公開發行程序。民國九十年六月經經濟部核准變更公司名稱為「喬山
健康科技股份有限公司」。民國九十一年六月二十六日向台灣證券交易所提出股票上市買賣申請，並經核准於民國九十二
年一月九日正式掛牌上市，其註冊地及主要營運據點位於台中市大雅區東大路2段999號。

</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="DateAndProceduresOfAuthorisationForIssueOfFinancialStatements">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">通過財報之日期及程序</th>
					</tr> 
					<tr>
						<td>　 通過財報之日期及程序</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DateAndProceduresOfAuthorisationForIssueOfFinancialStatements" contextRef="From20220101To20221231" escape="true">
本公司及子公司(以下簡稱本集團)民國一一一年度及一一０年度之合併財務報告業經董事會於民國一一二年三月十四日通
過發布。

</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">新發布及修訂準則及解釋之適用</th>
					</tr> 
					<tr>
						<td>　 新發布及修訂準則及解釋之適用</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations" contextRef="From20220101To20221231" escape="true">
1.首次適用國際財務報導準則而產生之會計政策變動

  本集團已採用金融監督管理委員會(以下簡稱金管會)已認可且自民國一一一年一月一日以後開始之會計年度適用之國際
  財務報導準則、國際會計準則、國際財務報導解釋或解釋公告，新準則及修正之首次適用對本集團並無重大影響。

2.截至財務報告通過發布日為止，本集團尚未採用下列國際會計準則理事會已發布且金管會已認可之新發布、修訂及修正
  準則或解釋：

                                                                                     國際會計準則理事會
  項次                         新發布/修正/修訂準則及解釋                               發布之生效日
  ——  ————————————————————————————————————  ————————————
   1    揭露倡議—會計政策（國際會計準則第1號之修正）                                 民國112年1月1日
   2    會計估計之定義（國際會計準則第8號之修正）                                     民國112年1月1日
   3    與單一交易所產生之資產及負債有關之遞延所得稅（國際會計準則第12號之修正）      民國112年1月1日

  (1)揭露倡議—會計政策（國際會計準則第1號之修正）

     此修正係改善會計政策之揭露，以提供投資者及其他財務報表主要使用者更有用之資訊。

  (2)會計估計之定義（國際會計準則第8號之修正）

     此修正直接定義會計估計，並對國際會計準則第8號「會計政策、會計估計變動及錯誤」進行其他修正，以協助企業
     區分會計政策變動與會計估計變動。

  (3)與單一交易所產生之資產及負債有關之遞延所得稅（國際會計準則第12號之修正）

     此修正係限縮國際會計準則第12號「所得稅」第15及24段中有關遞延所得稅認列豁免之範圍，使該豁免不適用於原
     始認列時產生相同金額之應課稅及可減除暫時性差異之交易。

  以上為國際會計準則理事會已發布，金管會已認可且自民國112年1月1日以後開始之會計年度適用之新發布、修訂及修
  正之準則或解釋，該新公布或修正準則、或解釋對本集團並無重大影響。

3.截至財務報告通過發布日為止，本集團未採用下列國際會計準則理事會已發布但金管會尚未認可之新發布、修訂及修正
  準則或解釋：

                                                                                     國際會計準則理事會
  項次                         新發布/修正/修訂準則及解釋                               發布之生效日
  ——  ————————————————————————————————————  ————————————
   1    國際財務報導準則第10號「合併財務報表」及國際會計準則第28號「投資關聯企業  待國際會計準則理事會決定
        及合資」之修正－投資者與其關聯企業或合資間之資產出售或投入
   2    國際財務報導準則第17號「保險合約」                                            民國112年1月1日
   3    負債分類為流動或非流動(國際會計準則第1號之修正)                               民國113年1月1日
   4    售後租回中之租賃負債(國際財務報導準則第16號之修正)                            民國113年1月1日
   5    合約中之非流動負債(國際會計準則第1號之修正)                                   民國113年1月1日

  (1)國際財務報導準則第10號「合併財務報表」及國際會計準則第28號「投資關聯企業及合資」之修正－投資者與其關
     聯企業或合資間之資產出售或投入

     此計畫係為處理國際財務報導準則第10號「合併財務報表」與國際會計準則第28號「投資關聯企業及合資」間，有
     關以子公司作價投資關聯企業或合資而喪失控制之不一致。國際會計準則第28號規定投入非貨幣性資產以交換關聯
     企業或合資之權益時，應依順流交易之處理方式銷除所產生利益或損失之份額；國際財務報導準則第10號則規定應
     認列喪失對子公司之控制時之全數利益或損失。此修正限制國際會計準則第28號之前述規定，當構成國際財務報導
     準則第3號所定義為業務之資產出售或投入時，其所產生之利益或損失應全數認列。

     此修正亦修改國際財務報導準則第10號使得投資者與其關聯企業或合資間，當出售或投入不構成國際財務報導準則
     第3號所定義業務之子公司時，其產生之利益或損失，僅就非屬投資者所享有份額之範圍認列。

  (2)國際財務報導準則第17號「保險合約」

     此準則提供保險合約全面性之模型，含括所有會計相關部分(認列、衡量、表達及揭露原則)，準則之核心為一般模
     型，於此模型下，原始認列以履約現金流量及合約服務邊際兩者之合計數衡量保險合約群組；於每一報導期間結束
     日之帳面金額為剩餘保障負債及已發生理賠負債兩者之總和。

     除一般模型外，並提供具直接參與特性合約之特定適用方法(變動收費法)；及短期合約之簡化法(保費分攤法)。

     此準則於民國106年5月發布後，另於民國109年及110年發布修正，該等修正除於過渡條款中將生效日延後2年(亦即
     由原先民國110年1月1日延後至民國112年1月1日)並提供額外豁免外，並藉由簡化部分規定而降低採用此準則成本，
     以及修改部分規定使部分情況更易於解釋。此準則之生效將取代過渡準則(亦即國際財務報導準則第4號「保險合約
     」)

  (3)負債分類為流動或非流動(國際會計準則第1號之修正)

     此係針對會計準則第1號「財務報表之表達」第69段至76段中負債分類為流動或非流動進行修正。

  (4)售後租回中之租賃負債(國際財務報導準則第16號之修正)

     此係針對國際財務報導準則第16號「租賃」賣方兼承租人於售後租回交易增加額外會計處理以增進準則之一致適用。

  (5)合約中之非流動負債(國際會計準則第1號之修正)

     此修正係增進企業提供有關長期債務合約之資訊。說明對於報導期間後十二個月須遵守之合約約定，不影響該等負
     債於報導期間結束日分類為流動或非流動。

  以上國際會計準則理事會已發布但金管會尚未認可之準則或解釋，其實際適用日期以金管會規定為準，該新公布或修正
  準則、或解釋對本集團並無重大影響。

</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="SummaryOfSignificantAccountingPolicies">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">重大會計政策之彙總說明</th>
					</tr> 
					<tr>
						<td>　 遵循聲明</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:StatementOfIFRSAndRelatedRegulationsCompliance" contextRef="From20220101To20221231" escape="true">
本集團民國一一一年度及一一０年度之合併財務報告係依據證券發行人財務報告編製準則及經金管會認可之國際財務報導
準則、國際會計準則、國際財務報導解釋及解釋公告編製。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 編製基礎</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:BasisOfPreparation" contextRef="From20220101To20221231" escape="true">
合併財務報表除以公允價值衡量之金融工具外，係以歷史成本為編製基礎。除另行註明者外，合併財務報表均以新台幣仟
元為單位。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 合併報表編製原則</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:PrinciplesOfConsolidation" contextRef="From20220101To20221231" escape="true">
當本公司暴露於來自對被投資者之參與之變動報酬或對該等變動報酬享有權利，且透過其對被投資者之權力有能力影響該
等報酬時，控制即達成。特別是，本公司僅於具有下列三項控制要素時，本公司始控制被投資者：

(1)對被投資者之權力(亦即具有賦予其現時能力以主導攸關活動之既存權利)
(2)來自對被投資者之參與之變動報酬之暴險或權利，及
(3)使用其對被投資者之權力以影響投資者報酬金額之能力

當本公司直接或間接持有少於多數之被投資者表決權或類似權利時，本公司考量所有攸關事實及情況以評估其是否對被投
資者具有權力，包括：

(1)與被投資者其他表決權持有人間之合約協議
(2)由其他合約協議所產生之權利
(3)表決權及潛在表決權

當事實及情況顯示三項控制要素中之一項或多項發生變動時，本公司即重評估是否仍控制被投資者。

子公司自收購日(即本集團取得控制之日)起，即全部編入合併報表中，直到喪失對子公司控制之日為止。子公司財務報表
之會計期間及會計政策與母公司一致。所有集團內部帳戶餘額、交易、因集團內部交易所產生之未實現內部利得與損失及
股利，係全數銷除。

對子公司持股之變動，若未喪失對子公司之控制，則該股權變動係以權益交易處理。

子公司綜合損益總額係歸屬至本公司業主及非控制權益，即使非控制權益因而產生虧損餘額亦然。

若本集團喪失對子公司之控制，則

(1)除列子公司之資產(包括商譽)和負債；
(2)除列任何非控制權益之帳面金額；
(3)認列取得對價之公允價值；
(4)認列所保留任何投資之公允價值；
(5)認列任何利益或虧損為當期損益；
(6)重分類母公司之前認列於其他綜合損益之項目金額為當期損益。

</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th colspan='30' rowspan='1' style="text-align:left">列入合併財務報表之子公司</th> 
					</tr>
					<tr> 
						<th colspan='1' rowspan='2' style="text-align:center">投資公司名稱</th> 
						<th colspan='1' rowspan='2' style="text-align:center">子公司名稱</th> 
						<th colspan='1' rowspan='2' style="text-align:center">業務性質</th> 
						<th colspan='2' rowspan='1' style="text-align:center">所持股權百分比</th> 
						<th colspan='1' rowspan='2' style="text-align:center">說明</th> 
					</tr>
					<tr> 
						<th colspan='1' rowspan='1' style="text-align:center">本期</th> 
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th> 
					</tr>
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">海外投資控股公司</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech (Vietnam) Company Limited</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies, S.A. de C.V.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Canada Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">海外投資控股公司</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. UK Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">44.43</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">44.43</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Retail Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Philippines,Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Care Co., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">按摩椅研發、製造及買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">78.90</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">78.90</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Industry (Viet Nam) Company Limited</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">健身器材之製造及心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Rus Limited Liability Company.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Fuji Medical Instruments MFG. Co., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">按摩椅研發、製造及買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">60.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">本期(註1)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. North America, Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">健身器材之製造及心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">PT Johnson Health Tech Indonesia</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Turkey Spor Ve Saglik Malzemeleri Ticaret Anonim Sirketi</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.99</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.99</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">去年同期(註2)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech SA Proprietary Limited</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">去年同期(註3)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">JHT FIT Company Limited</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">影音傳輸及串流服務提供</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">去年同期(註4)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Digital UK Limited</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">影音傳輸及串流服務提供</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">去年同期(註5)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Korea Co., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">健身器材之製造及心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">本期(註6)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech India Pvt Ltd</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">本期(註7)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">喬山健康科技(香港)有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">本期(註8)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Fitness (Malaysia) Sdn.. Bhd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.38</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">本期(註9)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. UK Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">55.57</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">55.57</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">健身器材之製造及心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. GmbH</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.77</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.77</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies Iberica, SL</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.99</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.99</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech France</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Japan Co., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.78</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.78</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. (Thailand) Co., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">95.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">95.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Italia S.P.A.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.82</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.82</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Fitness (Malaysia) Sdn.. Bhd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.38</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">本期(註9)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. (Schweiz) GmbH</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Netherland B.V.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">健身器材之製造及外銷業務</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">喬山健康科技(香港)有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">本期(註8)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Care Co., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">按摩椅研發、製造及買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">21.10</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">21.10</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Industrial do Brasil Ltda.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">健身器材之製造及心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.99</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.99</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">World of Leasing GmbH</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等租賃業務</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Australia Pty., Ltd</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Poland Sp.    z o.o.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Style Retail Vietnam Company Limited</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">喬山餐飲管理(上海)有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">食品販售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">喬富貿易（上海）有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">食品販售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech UAE LLC</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Retail Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">2nd wind Exercise Equipment, Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Retail Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Leisure Fitness Equipment,LLC</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Retail Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">The Gym Store, LLC (Busy Body)</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Retail Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Trading, Inc</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Canada Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies Canada Commercial Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech North America Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech NA Manufacturing LLC</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">健身器材之製造及銷售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Australia Pty., Ltd</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech New Zealand</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Netherlands B.V.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Denmark Aps</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Italia S.P.A.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Hellas SA</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.73</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.73</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Italia S.P.A.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Romania SA</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Italia S.P.A.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech CZ ＆ SK a.s.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Japan Co., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Johnson Digital Japan Co., Ltd.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">影音傳輸及串流服務提供</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">本期(註10)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan='1'>備註</th>
						<td colspan='7' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-TheConsolidatedEntities" contextRef="From20220101To20221231" escape="true">註1：本公司於民國一一一年十二月十三日收購原於日本設立60%控股之子公司 Fuji Medical Instruments MFG. Co., Ltd.剩餘之40%股權。
註2 ：本公司於民國一一０年二月三日於土耳其設立99.99%控股之子公司 Johnson Health Tech Turkey Spor Ve Saglik Malzemeleri Ticaret Anonim Sirketi。
註3 ：本公司於民國一一０年一月二十五日於南非設立100%控股之子公司 Johnson Health Tech SA Proprietary Limited。
註4 ：本公司於民國一一０年七月二日於泰國設立100%控股之子公司 JHT FIT Company Limited。
註5 ：本公司於民國一一０年十一月十六日於英國設立100%控股之子公司 Johnson Health Tech Digital UK Limited。
註6 ：本公司於民國一一一年一月三日於韓國設立100%控股之子公司 Johnson Health Tech Korea Co., Ltd.。
註7 ：本公司於民國一一一年五月二十三日於印度設立100%控股之子公司 Johnson Health Tech India Pvt Ltd。
註8 ：本公司為營運所需，於民國一一一年第三季調整投資架構，將Johnson International Holding Corp., Ltd.100%持有之子公司喬山健康科技(香港)有限公司，
　　　移轉本公司100%控股。
註9 ：本公司為營運所需，於民國一一一年第四季調整投資架構，將Johnson International Holding Corp., Ltd.99.38%持有之子公司Johnson Fitness (Malaysia) 
　　　Sdn.. Bhd.，移轉本公司99.38%控股。
註10：本集團於民國一一一年六月一日由Johnson Health Tech Japan Co., Ltd.於日本成立100%控股之子公司 Johnson Digital Japan Co., Ltd.。</ix:nonNumeric></pre></td>
					</tr> 
				</table> 
			<div style="text-align:center">未列入合併財務報表之子公司</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr>
						<td>　 外幣</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ForeignCurrencies" contextRef="From20220101To20221231" escape="true">
外幣交易

本集團之合併財務報表係以本公司之功能性貨幣新台幣表達。集團內的每一個體係自行決定其功能性貨幣，並以該功能性
貨幣衡量其財務報表。

集團內個體之外幣交易係以交易日匯率換算為其功能性貨幣記錄。於每一報導期間結束日，外幣貨幣性項目以該日收盤匯
率換算；以公允價值衡量之外幣非貨幣性項目，以決定公允價值當日之匯率換算；以歷史成本衡量之外幣非貨幣性項目，
以原始交易日之匯率換算。

除下列所述者外，因交割或換算貨幣性項目所產生之兌換差額，於發生當期認列為損益：

(1)為取得符合要件之資產所發生之外幣借款，其產生之兌換差額若視為對利息成本之調整者，為借款成本之一部分，予
   以資本化作為該項資產之成本。

(2)適用國際會計準則第39號「金融工具：認列與衡量」之外幣項目，依金融工具之會計政策處理。

(3)構成報導個體對國外營運機構淨投資一部分之貨幣性項目，所產生之兌換差額原始係認列為其他綜合損益，並於處分
   該淨投資時，自權益重分類至損益。

當非貨幣性項目之利益或損失認列為其他綜合損益時，該利益或損失之任何兌換組成部分認列為其他綜合損益。當非貨幣
性項目之利益或損失認列為損益時，該利益或損失之任何兌換組成部分認列為損益。

外幣財務報表之換算

編製合併財務報表時，國外營運機構之資產與負債係以該資產負債表日之收盤匯率換算為新台幣，收益及費損項目係以當
期平均匯率換算。因換算而產生之兌換差額認列為其他綜合損益，並於處分該國外營運機構時，將先前已認列於其他綜合
損益並累計於權益項下之單獨組成部分之累計兌換差額，於認列處分損益時，自權益重分類至損益。涉及對包含國外營運
機構之子公司喪失控制之部分處分，及部分處分對包含國外營運機構之關聯企業或聯合協議之權益後，所保留之權益係一
包含國外營運機構之金融資產者，亦按處分處理。

在未喪失控制下部分處分包含國外營運機構之子公司時，按比例將認列於其他綜合損益之累計兌換差額重新歸屬予該國外
營運機構之非控制權益，而不認列為損益；在未喪失重大影響或聯合控制下，部分處分包含國外營運機構之關聯企業或聯
合協議時，累計兌換差額則按比例重分類至損益。

本集團因收購國外營運機構產生之商譽及對其資產與負債帳面金額所作之公允價值調整，視為該國外營運機構之資產及負
債，並以其功能性貨幣列報。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 資產與負債區分流動與非流動之標準</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ClassificationOfCurrentAndNoncurrentAssetsAndLiabilities" contextRef="From20220101To20221231" escape="true">
有下列情況之一者，分類為流動資產，非屬流動資產，則分類為非流動資產：

(1)預期於其正常營業週期中實現該資產，或意圖將其出售或消耗。
(2)主要為交易目的而持有該資產。
(3)預期於報導期間後十二個月內實現該資產。
(4)現金或約當現金，但於報導期間後至少十二個月將該資產交換或用以清償負債受到限制者除外。

有下列情況之一者，分類為流動負債，非屬流動負債，則分類為非流動負債：

(1)預期於其正常營業週期中清償該負債。
(2)主要為交易目的而持有該負債。
(3)預期於報導期間後十二個月內到期清償該負債。
(4)不能無條件將清償期限遞延至報導期間後至少十二個月之負債。負債之條款，可能依交易對方之選擇，以發行權益工
   具而導致其清償者，並不影響其分類。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 現金及約當現金</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CashAndCashEquivalents" contextRef="From20220101To20221231" escape="true">
現金及約當現金係庫存現金、活期存款及可隨時轉換成定額現金且價值變動風險甚小之短期並具高度流動性之定期存款或
投資(包括合約期間3個月內之定期存款)。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 金融工具</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialInstruments" contextRef="From20220101To20221231" escape="true">
金融資產與金融負債於本集團成為該金融工具合約條款之一方時認列。

符合國際財務報導準則第9號「金融工具」適用範圍之金融資產與金融負債，於原始認列時，係依公允價值衡量，直接可
歸屬於金融資產與金融負債(除分類為透過損益按公允價值衡量之金融資產及金融負債外)取得或發行之交易成本，係從該
金融資產及金融負債之公允價值加計或減除。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssets" contextRef="From20220101To20221231" escape="true">
金融資產之認列與衡量

本集團所有慣例交易金融資產之認列與除列，採交易日會計處理。

本集團以下列兩項為基礎將金融資產分類為後續按攤銷後成本衡量、透過其他綜合損益按公允價值衡量或透過損益按公允
價值衡量之金融資產：

A.管理金融資產之經營模式
B.金融資產之合約現金流量特性

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 透過損益按公允價值衡量之金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="From20220101To20221231" escape="true">
除前述符合特定條件而按攤銷後成本衡量或透過其他綜合損益按公允價值衡量外，金融資產均採透過損益按公允價值衡量
，並以透過損益按公允價值衡量之金融資產列報於資產負債表。

此類金融資產以公允價值衡量，其再衡量產生之利益或損失認列為損益，該認列為損益之利益或損失包含該金融資產所收
取之任何股利或利息。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 透過其他綜合損益按公允價值衡量之金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="From20220101To20221231" escape="true">

同時符合下列兩條件之金融資產，按透過其他綜合損益按公允價值衡量，並以透過其他綜合損益按公允價值衡量之金融資
產列報於資產負債表：

A.管理金融資產之經營模式：收取合約現金流量及出售金融資產
B.金融資產之合約現金流量特性：現金流量完全為支付本金及流通在外本金金額之利息

此類金融資產相關損益之認列說明如下：

A.除列或重分類前，除減損利益或損失與外幣兌換損益認列於損益外，其利益或損失係認列於其他綜合損益
B.除列時，先前認列於其他綜合損益之累積利益或損失係自權益重分類至損益作為重分類調整
C.以有效利息法(以有效利率乘以金融資產總帳面金額)或下列情況計算之利息，則認列於損益：
  (a)如屬購入或創始之信用減損金融資產，以信用調整後有效利率乘以金融資產攤銷後成本
  (b)非屬前者，惟續後變成信用減損者，以有效利率乘以金融資產攤銷後成本

此外，對於屬國際財務報導準則第9號適用範圍之權益工具，且該權益工具既非持有供交易，亦非適用國際財務報導準則
第3號之企業合併中之收購者所認列之或有對價，於原始認列時，選擇(不可撤銷)將其後續公允價值變動列報於其他綜合
損益。列報於其他綜合損益中之金額後續不得移轉至損益(處分該等權益工具時，將列入其他權益項目之累積金額，直接
轉入保留盈餘)，並以透過其他綜合損益按公允價值衡量之金融資產列報於資產負債表。投資之股利則認列於損益，除非
該股利明顯代表部分投資成本之回收。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 按攤銷後成本衡量之金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssetsAtAmortisedCost" contextRef="From20220101To20221231" escape="true">
同時符合下列兩條件之金融資產，按攤銷後成本衡量，並以應收票據、應收帳款、按攤銷後成本衡量之金融資產及其他應
收款等項目列報於資產負債表：

A.管理金融資產之經營模式：持有金融資產以收取合約現金流量
B.金融資產之合約現金流量特性：現金流量完全為支付本金及流通在外本金金額之利息

此等金融資產(不包括涉及避險關係者)後續以攤銷後成本【原始認列時衡量之金額，減除已償付之本金，加計或減除該原
始金額與到期金額間差額之累積攤銷數（使用有效利息法），並調整備抵損失】衡量。於除列、透過攤銷程序或認列減損
利益或損失時，將其利益或損失認列於損益。

以有效利息法(以有效利率乘以金融資產總帳面金額)或下列情況計算之利息，則認列於損益：

A.如屬購入或創始之信用減損金融資產，以信用調整後有效利率乘以金融資產攤銷後成本
B.非屬前者，惟後續變成信用減損者，以有效利率乘以金融資產攤銷後成本

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融資產減損</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ImpairmentOfFinancialAssets" contextRef="From20220101To20221231" escape="true">
本集團對透過其他綜合損益按公允價值衡量之債務工具投資及按攤銷後成本衡量之金融資產，係以預期信用損失認列並衡
量備抵損失。透過其他綜合損益按公允價值衡量之債務工具投資係將備抵損失認列於其他綜合損益，且不減少該投資之帳
面金額。

本集團以反映下列各項之方式衡量預期信用損失：

A.藉由評估各可能結果而決定之不偏且以機率加權之金額
B.貨幣時間價值
C.與過去事項、現時狀況及未來經濟狀況預測有關之合理且可佐證之資訊(於資產負債表日無須過度成本或投入即可取得
  者)

衡量備抵損失之方法說明如下：

A.按12個月預期信用損失金額衡量：包括金融資產自原始認列後信用風險未顯著增加，或於資產負債表日判定為信用風險
  低者。此外，亦包括前一報導期間按存續期間預期信用損失金額衡量備抵損失，但於本期資產負債表日不再符合自原始
  認列後信用風險已顯著增加之條件者。
B.存續期間預期信用損失金額衡量：包括金融資產自原始認列後信用風險已顯著增加，或屬購入或創始之信用減損金融資
  產。
C.對於屬國際財務報導準則第15號範圍內之交易所產生之應收帳款或合約資產，本集團採用存續期間預期信用損失金額衡
  量備抵損失。
D.對於屬國際財務報導準則第16號範圍內之交易所產生之應收租賃款，本集團採用存續期間預期信用損失金額衡量備抵損
  失。

本集團於每一資產負債表日，以比較金融工具於資產負債表日與原始認列日之違約風險之變動，評估金融工具於原始認列
後之信用風險是否已顯著增加。另與信用風險相關資訊請詳附註十二。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融資產之除列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DerecognitionOfFinancialAssets" contextRef="From20220101To20221231" escape="true">
本集團持有之金融資產於符合下列情況之一時除列:

A.來自金融資產現金流量之合約權利終止。
B.已移轉金融資產且將該資產所有權之幾乎所有風險及報酬移轉予他人。
C.既未移轉亦未保留資產所有權之幾乎所有風險及報酬，但已移轉對資產之控制。

一金融資產整體除列時，其帳面金額與已收取或可收取對價加計認列於其他綜合損益之任何累計利益或損失總和間之差額
係認列於損益。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 金融負債及權益工具</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialLiabilitiesAndEquityInstruments" contextRef="From20220101To20221231" escape="true">
權益工具

權益工具係指表彰本集團於資產減除所有負債後剩餘權益之任何合約，本集團發行之權益工具係以取得之價款扣除直接發
行成本後之金額認列。

複合工具

本集團對所發行之可轉換公司債依其合約條款確認金融負債及權益組成要素。另對所發行之轉換公司債，係於區分權益要
素前評估嵌入之買、賣權之經濟特性及風險是否與主債務商品緊密關聯。

不涉及衍生工具之負債部分，其公允價值使用性質相當且不具轉換特性債券之市場利率評估，於轉換或贖回清償前，此部
分金額分類為以攤銷後成本衡量之金融負債；至於其他與主契約經濟特性風險不緊密關聯之嵌入式衍生工具部分(例如嵌
入之買回權及贖回權經確認其執行價格無法幾乎等於債務商品於每一執行日之攤銷後成本)，除屬權益組成要素外，分類
為負債組成要素，並於後續期間以透過損益按公允價值衡量；權益要素之金額則以轉換公司債公允價值減除負債組成部分
決定之，其帳面金額於後續之會計期間不予重新衡量。若所發行之轉換公司債不具權益要素，則依國際財務報導準則第9
號混合工具之方式處理。

交易成本依照原始認列可轉換公司債分攤予負債及權益組成部分之比例，分攤至負債及權益組成部分。

轉換公司債持有人於該轉換公司債到期前要求行使轉換權利時，先將負債組成要素之帳面金額調整至轉換當時應有之帳面
金額，作為發行普通股之入帳基礎。

金融負債

符合國際財務報導準則第9號適用範圍之金融負債於原始認列時，分類為透過損益按公允價值衡量之金融負債或以攤銷後
成本衡量之金融負債。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 負債或權益之分類</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ClassificationOfFinancialLiabilitiesAndEquityInstruments" contextRef="From20220101To20221231" escape="true">
本集團發行之負債及權益工具係依據合約協議之實質與金融負債及權益工具之定義分類為金融負債或權益。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 透過損益按公允價值衡量之金融負債</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="From20220101To20221231" escape="true">
透過損益按公允價值衡量之金融負債，包括持有供交易之金融負債及指定為透過損益按公允價值衡量之金融負債。

當符合下列條件之一，分類為持有供交易：

A.其取得之主要目的為短期內出售；
B.於原始認列時即屬合併管理之可辨認金融工具組合之一部分，且有近期該組合為短期獲利之操作型態之證據；或
C.屬衍生工具(財務保證合約或被指定且有效之避險工具之衍生工具除外)。

對於包含一個或多個嵌入式衍生工具之合約，可指定整體混合(結合)合約為透過損益按公允價值衡量之金融負債；當符合
下列因素之一而可提供更攸關之資訊時，於原始認列時指定為透過損益按公允價值衡量：

A.該指定可消除或重大減少衡量或認列不一致；或
B.一組金融資產、金融負債或兩者，依書面之風險管理或投資策略，以公允價值基礎管理並評估其績效，且合併公司內部
  提供予管理階層之該投資組合資訊，亦以公允價值為基礎。

此類金融負債再衡量產生之利益或損失認列為損益，該認列為損益之利益或損失包含該金融負債所支付之任何利息。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 按攤銷後成本衡量之金融負債</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialLiabilitiesAtAmortisedCost" contextRef="From20220101To20221231" escape="true">
以攤銷後成本衡量之金融負債包括應付款項及借款等，於原始認列後，續後以有效利率法衡量。當金融負債除列及透過有
效利率法攤提時，將其相關損益及攤銷數認列於損益。

攤銷後成本之計算考量取得時之折價或溢價及交易成本。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融負債之除列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DerecognitionOfFinancialLiabilities" contextRef="From20220101To20221231" escape="true">
當金融負債之義務解除、取消或失效時，則除列該金融負債。

當本集團與債權人間就具重大差異條款之債務工具進行交換，或對現有金融負債之全部或部分條款作重大修改(不論是否
因財務困難)，以除列原始負債並認列新負債之方式處理，除列金融負債時，將其帳面金額與所支付或應支付對價總額(包
括移轉之非現金資產或承擔之負債)間之差額認列於損益。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融資產及負債之互抵</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:OffsettingFinancialAssetsAndFinancialLiabilities" contextRef="From20220101To20221231" escape="true">
金融資產及金融負債僅於已認列金額目前具互抵之法律行使權利且有意圖以淨額交割或同時變現資產及清償負債時，方能
予以互抵並以淨額列示於資產負債表。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 衍生金融工具及避險會計</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DerivativeInstrumentsAndHedgeAccounting" contextRef="From20220101To20221231" escape="true">
本集團所持有或發行之衍生工具係用以規避匯率風險及利率風險，其中屬指定且為有效避險者，於資產負債表列報為避險
之金融資產或負債；其餘非屬指定且為有效避險者，則於資產負債表列報為透過損益按公允價值衡量之金融資產或金融負
債。

衍生工具之原始認列係以衍生工具合約簽訂日之公允價值衡量，並於續後採公允價值衡量。當衍生工具之公允價值為正數
時，為金融資產；公允價值為負數時，則為金融負債。衍生工具公允價值變動直接認列於損益，惟涉及現金流量避險及國
外營運機構淨投資避險屬有效部分者，則認列於損益或權益項下。

主契約為非金融資產或金融負債者，當嵌入於主契約之衍生工具，其經濟特性及風險與主契約並非緊密關聯，且主契約非
屬透過損益按公允價值衡量時，該嵌入式衍生工具應視為獨立之衍生工具處理。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 存貨</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Inventories" contextRef="From20220101To20221231" escape="true">
存貨按逐項比較之成本與淨變現價值孰低法評價。

成本指為使存貨達到可供銷售或可供生產狀態及地點所產生之成本：

原物料－以實際進貨成本，採加權平均法。
製成品及在製品－包括直接原料、人工及以正常產能分攤之固定製造費用，但不包含借款成本。

淨變現價值指在正常情況下，估計售價減除至完工尚須投入之成本及銷售費用後之餘額。

勞務提供係依據國際財務報導準則第15號之規定處理，非屬存貨範圍。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 不動產（、廠房）及設備</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:PropertyPlantAndEquipment" contextRef="From20220101To20221231" escape="true">
不動產、廠房及設備係以取得成本為認列基礎，並減除累計折舊及累計減損後列示，前述成本包含不動產、廠房及設備之
拆卸、移除及復原其所在地點之成本及因未完工程所產生之必要利息支出。不動產、廠房及設備之各項組成若屬重大，則
將單獨提列折舊。當不動產、廠房及設備之重大組成項目須被定期重置，本集團將該項目視為個別資產並以特定耐用年限
及折舊方法分別認列。該等被重置部分之帳面金額，則依國際會計準則第16號「不動產、廠房及設備」之除列規定予以除
列。重大檢修成本若符合認列條件，係視為替換成本而認列為廠房及設備帳面金額之一部分，其他修理及維護支出則認列
至損益。

折舊係以平均法按下列資產之估計耐用年限計提：

   資產項目                  耐用年限
———————    ———————————————
  房屋及建築        3∼55年
  機器設備          3∼12年
  運輸設備          5∼10年
  辦公設備          2∼12年
  模具設備          2∼5年
  租賃改良          依租賃年限或耐用年限孰短者
  其他設備          2∼12年

不動產、廠房及設備之項目或任一重要組成部分於原始認列後，若予處分或預期未來不會因使用或處分而有經濟效益之流
入，則予以除列並認列營業外損益。

不動產、廠房及設備之殘值、耐用年限及折舊方法係於每一財務年度終了時評估，若預期值與先前之估計不同時，該變動
視為會計估計變動。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 投資性不動產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:InvestmentProperty" contextRef="From20220101To20221231" escape="true">
本集團自有之投資性不動產係以原始成本衡量，並包含取得該項資產之交易成本。投資性不動產之帳面金額包括於達到成
本可認列之條件下，因修繕或新增現有投資性不動產而投入之成本，但一般日常發生之維修費用則不作為其成本之一部分
。於原始認列後，除依國際財務報導準則第5號「待出售非流動資產及停業單位」符合分類為待出售(或包括於分類為待出
售之處分群組中)之條件者外，投資性不動產之衡量係採成本模式，依國際會計準則第16號「不動產、廠房及設備」對該
模式之規定處理，惟若其由承租人以使用權資產所持有且依國際財務報導準則第5號之規定非為待出售者，係依國際財務
報導準則第16號之規定處理。

折舊係以直線法按下列資產之估計耐用年限計提：

   資產項目                  耐用年限
———————    ———————————————
    建築物                   30∼50年

投資性不動產在處分、或永久不再使用且預期無法由處分產生未來經濟效益之情況下，即予以除列並認列損益。

本集團依資產實際用途決定轉入或轉出投資性不動產。

當不動產符合或不再符合投資性不動產定義且有證據顯示用途改變時，本集團將不動產轉列為投資性不動產或從投資性不
動產轉出。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 租賃</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Leasing" contextRef="From20220101To20221231" escape="true">
本集團就合約成立日評估該合約是否係屬(或包含)租賃。若合約轉讓對已辨認資產之使用之控制權一段時間以換得對價，
該合約係屬(或包含)租賃。為評估合約是否轉讓對已辨認資產之使用之控制權一段時間，本集團評估在整個使用期間是否
具有下列兩者：

(1)取得來自使用已辨認資產之幾乎所有經濟效益之權利；及
(2)主導已辨認資產之使用之權利。

對於合約係屬(或包含)租賃者，本集團將合約中每一租賃組成部分作為單獨租賃，並與合約中之非租賃組成部分分別處理
。對於合約包含一項租賃組成部分以及一項或多項之額外租賃或非租賃組成部分者，本集團以每一租賃組成部分之相對單
獨價格及非租賃組成部分之彙總單獨價格為基礎，將合約中之對價分攤至該租賃組成部分。租賃及非租賃組成部分之相對
單獨價格，以出租人(或類似供應者)分別對該組成部分(或類似組成部分)收取之價格為基礎決定。若可觀察之單獨價格並
非隨時可得，本集團最大化可觀察資訊之使用以估計該單獨價格。

集團為承租人

除符合並選擇短期租賃或低價值標的資產之租賃外，當本集團係租賃合約之承租人時，對所有租賃認列使用權資產及租賃
負債。

本集團於開始日，按於該日尚未支付之租賃給付之現值衡量租賃負債。若租賃隱含利率容易確定，租賃給付使用該利率折
現。若該利率並非容易確定，使用承租人增額借款利率。於開始日，計入租賃負債之租賃給付，包括與租賃期間內之標的
資產使用權有關且於該日尚未支付之下列給付：

(1)固定給付(包括實質固定給付)，減除可收取之任何租賃誘因；
(2)取決於某項指數或費率之變動租賃給付(採用開始日之指數或費率原始衡量)；
(3)殘值保證下承租人預期支付之金額；
(4)購買選擇權之行使價格，若本集團可合理確定將行使該選擇權；及
(5)租賃終止所須支付之罰款，若租賃期間反映承租人將行使租賃終止之選擇權。

開始日後，本集團按攤銷後成本基礎衡量租賃負債，以有效利率法增加租賃負債帳面金額，反映租賃負債之利息；租賃給
付之支付減少租賃負債帳面金額。

本集團於開始日，按成本衡量使用權資產，使用權資產之成本包含：

(1)租賃負債之原始衡量金額；
(2)於開始日或之前支付之任何租賃給付，減除收取之任何租賃誘因；
(3)承租人發生之任何原始直接成本；及
(4)承租人拆卸、移除標的資產及復原其所在地點，或將標的資產復原至租賃之條款及條件中所要求之狀態之估計成本。

使用權資產後續衡量以成本減除累計折舊及累計減損損失後列示，亦即適用成本模式衡量使用權資產。

若租賃期間屆滿時標的資產所有權移轉予本集團，或若使用權資產之成本反映本集團將行使購買選擇權，則自開始日起至
標的資產耐用年限屆滿時，對使用權資產提列折舊。否則，本集團自開始日起至使用權資產之耐用年限屆滿時或租賃期間
屆滿時兩者之較早者，對使用權資產提列折舊。

本集團適用國際會計準則第36號「資產減損」判定使用權資產是否發生減損並處理任何已辨認之減損損失。

除符合並選擇短期租賃或低價值標的資產之租賃外，本集團於資產負債表列報使用權資產及租賃負債，並於綜合損益表分
別列報與租賃相關之折舊費用及利息費用。

本集團對短期租賃及低價值標的資產之租賃，選擇按直線基礎或另一種有系統之基礎，將有關該等租賃之租賃給付於租賃
期間認列為費用。

集團為出租人

本集團於合約成立日將其每一租賃分類為營業租賃或融資租賃。租賃如移轉附屬於標的資產所有權之幾乎所有風險與報酬
，係分類為融資租賃；若未移轉，則分類為營業租賃。於開始日，本集團於資產負債表認列融資租賃下所持有之資產，並
按租賃投資淨額將其表達為應收融資租賃款。

對於合約包含租賃組成部分以及非租賃組成部分，本集團適用國際財務報導準則第15號規定分攤合約中之對價。

本集團按直線基礎或另一種有系統之基礎，將來自營業租賃之租賃給付認列為租金收入。對於營業租賃之非取決於某項指
數或費率之變動租賃給付，於發生時認列為租金收入。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 無形資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:IntangibleAssets" contextRef="From20220101To20221231" escape="true">
單獨取得之無形資產於原始認列時係以成本衡量。透過企業合併取得之無形資產成本為收購日之公允價值。無形資產於原
始認列後，係以其成本減除累計攤銷及累計減損損失後之金額作為帳面金額。不符合認列條件之內部產生無形資產不予資
本化，而係於發生時認列至損益。

無形資產之耐用年限區分為有限及非確定耐用年限。

有限耐用年限之無形資產係於其耐用年限內攤銷，並於存有減損跡象時進行減損測試。有限耐用年限之無形資產攤銷期間
及攤銷方法係至少於每一財務年度結束時進行複核。若資產之預估耐用年限與先前之估計不同或未來經濟效益消耗之預期
型態已發生改變，則攤銷方法或攤銷期間將予以調整並視為會計估計變動。

非確定耐用年限之無形資產不予攤銷，但於每一年度依個別資產或現金產生單位層級進行減損測試。非確定耐用年限之無
形資產係於每期評估是否有事件及情況繼續支持該資產之耐用年限仍屬非確定。若耐用年限由非確定改為有限耐用年限時
，則推延適用。

無形資產之除列所產生之利益或損失係認列至損益。

本集團無形資產會計政策彙總如下：

                         商標權　　　　　  專利權　　 　　電腦軟體成本　　　其他無形資產 　　 　 商譽
                    －－－－－－——  －－－－－－——  －－－－－－——  －－－－－－——  －－－－－－－
耐用年限             有限10-17年       有限2-7年         有限1-10年        有限3-5年         非確定
使用之攤銷方法       於估計效益年限    於專利權期間      於估計效益年限    於估計效益年限    不攤銷
                       以直線法攤銷      以直線法攤銷      以直線法攤銷      以直線法攤銷
內部產生或外部取得   外部取得          外部取得          外部取得          外部取得          外部取得

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 非金融資產減損</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ImpairmentOfNonFinancialAsset" contextRef="From20220101To20221231" escape="true">
本集團於每一報導期間結束日評估所有適用國際會計準則第36號「資產減損」之資產是否存有減損跡象。如有減損跡象或
須針對某一資產每年定期進行減損測試，本集團即以個別資產或資產所屬之現金產生單位進行測試。減損測試結果如資產
或資產所述現金產生單位之帳面金額大於其可回收金額，則認列減損損失。可回收金額為淨公允價值或使用價值之較高者
。

本集團於每一報導期間結束日針對商譽以外之資產，評估是否有跡象顯示先前已認列之減損損失可能已不存在或減少。如
存有此等跡象，本集團即估計該資產或現金產生單位之可回收金額。若可回收金額因資產之估計服務潛能變動而增加時，
則迴轉減損。惟迴轉後帳面金額不超過資產在未認列減損損失情況下，減除應提列折舊或攤銷後之帳面金額。

商譽所屬之現金產生單位或群組，不論有無減損跡象，係每年定期進行減損測試。減損測試結果如須認列減損損失，則先
行減除商譽，減除不足之數再依帳面金額之相對比例分攤至商譽以外之其他資產。商譽之減損，一經認列，嗣後不得以任
何理由迴轉。

繼續營業單位之減損損失及迴轉數係認列於損益。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 負債準備</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Provisions" contextRef="From20220101To20221231" escape="true">
負債準備之認列條件係因過去事件所產生之現時義務(法定義務或推定義務)，於清償義務時，很有可能需要流出具經濟效
益之資源，且該義務金額能可靠估計。當本集團預期某些或所有負債準備可被歸墊時，只有當歸墊幾乎完全確定時認列為
單獨資產。若貨幣時間價值影響重大時，負債準備以可適當反映負債特定風險之現時稅前利率折現。負債折現時，因時間
經過而增加之負債金額，認列為借款成本。

保固之負債準備

保固之負債準備係依銷售商品合約約定以及管理階層對於因保固義務所導致未來經濟效益流出最佳估計數(以歷史保固經
驗為基礎)估列。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 庫藏股票</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:TreasuryStock" contextRef="From20220101To20221231" escape="true">
本集團於取得母公司股票(庫藏股票)時係以取得成本認列並作為權益之減項。庫藏股票交易之價差認列於權益項下。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 收入之認列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:RevenueRecognition" contextRef="From20220101To20221231" escape="true">
本集團與客戶合約之收入主要包括銷售商品，會計處理分別說明如下：

銷售商品

本集團製造並銷售商品，於承諾之商品運送至客戶端且客戶取得其控制(即客戶主導該商品之使用並取得該商品之幾乎所
有剩餘效益之能力)時認列收入，主要商品為健身器材、心肺復甦健身機、重量訓練機、電動按摩椅等，以合約敘明之價
格為基礎認列收入，其餘銷售商品之交易，通常附有數量折扣(以特定期間累積銷售總額為基礎)。因此，收入以合約敘明
之價格為基礎，並減除估計之數量折扣金額。本集團以累積經驗並採期望值估計數量折扣產生之變動對價，惟其範圍僅限
於與變動對價相關之不確定性於後續消除時，所認列之累計收入金額高度很有可能不會發生重大迴轉之部分。在協議之特
定期間，對預期之數量折扣亦相對認列退款負債。

本集團提供之保固係基於所提供之商品會如客戶預期運作之保證，並依國際會計準則第37號之規定處理。

本集團銷售商品交易之授信期間為0~65天，大部分合約於商品移轉控制且具有無條件收取對價之權利時，即認列應收帳款
，該等應收帳款通常期間短且不具重大財務組成部分；少部分合約，具有已移轉商品予客戶惟仍未具無條件收取對價之權
利，則認列合約資產，合約資產另須依國際財務報導準則第9號規定按存續期間預期信用損失金額衡量備抵損失。然有部
分合約，由於簽約時即先向客戶收取部分對價，本集團承擔須於續後提供服務之義務，故認列為合約負債。

本集團前述合約負債轉列收入之期間通常不超過一年，並未導致重大財務組成部分之產生。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 借款成本</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:BorrowingCost" contextRef="From20220101To20221231" escape="true">
直接可歸屬於取得、建造或生產符合要件之資產的借款成本，予以資本化為該資產成本之一部分。其他所有借款成本則認
列為發生期間之費用。借款成本係包括與舉借資金有關而發生之利息及其他成本。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 政府補助</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:GovernmentGrants" contextRef="From20220101To20221231" escape="true">
本集團在能合理確信將符合政府補助所定條件，並可收到政府補助之經濟效益流入時，始認列政府補助收入。當補助與資
產有關時，政府補助則認列為遞延收入並於相關資產預期耐用年限分期認列為收益；當補助與費用項目有關時，政府補助
係以合理而有系統之方法配合相關成本之預期發生期間認列為收益。

本集團取得之非貨幣性政府補助時，以名目金額認列所收取之資產與補助，並於標的資產之預期耐用年限與效益消耗型態
分期等額於綜合損益表認列收益。與自政府或相關機構獲取低於市場利率之貸款或類似輔助視為額外的政府補助。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 員工福利</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:EmployeeBenefits" contextRef="From20220101To20221231" escape="true">
退職後福利計畫

本公司及國內子公司員工退休辦法適用於所有正式任用之員工，員工退休基金全數提存於勞工退休準備金監督委員會管理
，並存入退休基金專戶，由於上述退休金係以退休準備金監督委員會名義存入，與本公司及國內子公司完全分離，故未列
入上開合併財務報表中。國外子公司及分公司員工退休辦法係依當地法令規定辦理。

對於屬確定提撥計畫之退職後福利計畫，本公司及國內子公司每月負擔之員工退休金提撥率，不得低於員工每月薪資百分
之六，所提撥之金額認列為當期費用；國外子公司及分公司則依當地特定比例提撥並認列為當期費用。

對於屬確定福利計畫之退職後福利計畫，依據預計單位福利法於年度報導期間結束日按精算報告提列。淨確定福利負債(
資產)再衡量數包括計畫資產報酬與資產上限影響數之任何變動，並減除包含於淨確定福利負債(資產)淨利息之金額，以
及精算損益。淨確定福利負債(資產)再衡量數於發生時，列入其他綜合損益項下，並立即認列於保留盈餘。前期服務成本
為計畫修正或縮減所產生之確定福利義務現值之變動數，且於下列兩者較早之日期認列為費用：

(1)當計畫修正或縮減發生時；及
(2)當集團認列相關重組成本或離職福利時。

淨確定福利負債(資產)淨利息係由淨確定福利負債(資產)乘以折現率決定，兩者均於年度報導期間開始時決定，再考量該
期間淨確定福利負債(資產)因提撥金及福利支付產生之任何變動。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 股份基礎給付</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ShareBasedPayment" contextRef="From20220101To20221231" escape="true">
本集團與員工間權益交割之股份基礎給付交易，其成本係以權益工具之給與日公允價值衡量。公允價值係以適當之定價模
式衡量。

權益交割之股份基礎給付交易之成本係於服務條件及績效條件達成之期間內逐期認列，並相對認列權益之增加。於既得日
前每一報導期間結束日針對權益交割交易所認列之累計費用，係反映既得期間之經過及本集團對最終將既得之權益工具數
量之最佳估計。每一報導期間期初及期末針對股份基礎給付交易所認列之累計成本變動數，則認列至該期間之損益。

股份基礎給付獎酬最終若未符合既得條件，則無須認列任何費用。但權益交割交易之既得條件如係與市價條件或非既得條
件有關，則在所有服務或績效條件均已達成之情況下，無論市價條件或非既得條件是否達成，相關費用仍予以認列。

於修改權益交割交易條件時，則至少認列未修改下之原始給付成本。股份基礎交易之交易條件修改若增加股份基礎給付交
易之公允價值總數或對員工有利時，則認列額外之權益交割交易成本。

權益交割之股份基礎給付獎酬計畫若被取消，則視為於取消日即已既得，並立即認列尚未認列之剩餘股份基礎給付費用，
此包括企業或員工可控制之非既得條件並未達成之獎酬計畫。若原先取消之獎酬係由新的獎酬計畫取代且於給與日即被確
認將取代被取消之獎酬計畫，則將取消及新給與之獎酬計畫視同原始獎酬計畫之修改。

流通在外選擇權之稀釋效果將於計算稀釋每股盈餘時，以額外股份計算其稀釋效果。

發行限制員工權利股票時，係以給與日所給與之權益商品公允價值為基礎，於既得期間認列薪資費用及相對之權益增加；
於給與日時本集團認列員工未賺得酬勞，員工未賺得酬勞屬過渡科目，於合併資產負債表中作為權益減項，並依時間經過
轉列薪資費用。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 所得稅</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:IncomeTax" contextRef="From20220101To20221231" escape="true">
所得稅費用(利益)係指包含於決定本期損益中，與當期所得稅及遞延所得稅有關之彙總數。

當期所得稅

與本期及前期有關之本期所得稅負債(資產)，係以報導期間結束日已立法或實質性立法之稅率及稅法衡量。當期所得稅與
認列於其他綜合損益或直接認列於權益之項目有關者，係分別認列於其他綜合損益或權益而非損益。

未分配盈餘加徵營利事業所得稅部分，於股東會決議分配盈餘之日列為所得稅費用。

遞延所得稅

遞延所得稅係就報導期間結束日，資產與負債之課稅基礎與其於資產負債表之帳面金額間所產生之暫時性差異予以計算。

除下列兩者外，所有應課稅暫時性差異皆予認列為遞延所得稅負債：

(1)商譽之原始認列；或非屬企業合併交易所產生，且於交易當時既不影響會計利潤亦不影響課稅所得(損失)之資產或負
   債原始認列；

(2)因投資子公司、關聯企業及聯合協議權益所產生，其迴轉時點可控制且於可預見之未來很有可能不會迴轉之應課稅暫
   時性差異。

除下列兩者外，可減除暫時性差異、未使用課稅損失及未使用所得稅抵減產生之遞延所得稅資產，於很有可能有未來課稅
所得之範圍內認列：

(1)與非屬企業合併交易，且於交易當時既不影響會計利潤亦不影響課稅所得(損失)之資產或負債原始認列所產生之可減
   除暫時性差異有關；

(2)與投資子公司、關聯企業及聯合協議權益所產生之可減除暫時性差異有關，僅於可預見之未來很有可能迴轉且迴轉當
   時有足夠之課稅所得以供該暫時性差異使用之範圍內認列。

遞延所得稅資產及負債係以預期資產實現或負債清償當期之稅率衡量，該稅率並以報導期間結束日已立法或實質性立法之
稅率及稅法為基礎。

遞延所得稅資產及負債之衡量係反映報導期間結束日預期回收資產或清償負債帳面金額之方式所產生之租稅後果。遞延所
得稅與不列於損益之項目有關者，亦不認列於損益，而係依其相關交易認列於其他綜合損益或直接認列於權益。遞延所得
稅資產於每一報導期間結束日予以重新檢視並認列。

遞延所得稅資產與負債僅於本期所得稅資產及本期所得稅負債之互抵具有法定執行權，且遞延所得稅係屬同一納稅主體並
與由同一稅捐機關課徵之所得稅有關時，可予互抵。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 企業合併</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:BusinessCombination" contextRef="From20220101To20221231" escape="true">
企業合併係採用收購法進行會計處理。企業合併之移轉對價、所取得之可辨認資產及承擔之負債，係以收購日之公允價值
衡量。收購者針對每一企業合併，係以公允價值或被收購者可辨認淨資產之相對比例衡量非控制權益。所發生之收購相關
成本係當期費用化並包括於管理費用。

本集團收購業務時，係依據收購日所存在之合約條件、經濟情況及其他相關情況，進行資產與負債分類與指定是否適當之
評估，包括被收購者所持有主契約中嵌入式衍生金融工具之分離考量。

企業合併如係分階段完成者，則收購者先前所持有被收購者之權益，係以收購日之公允價值重新衡量，並將所產生之利益
或損失認列為當期損益。

收購者預計移轉之或有對價將以收購日之公允價值認列。被視為資產或負債之或有對價，其續後之公允價值變動將依國際
財務報導準則第9號規定認列為當期損益或其他綜合損益之變動。惟或有對價如係分類為權益時，則在其最終於權益項下
結清前，均不予以重新衡量。

商譽之原始衡量係所移轉之對價加計非控制權益後之總數，超過本集團所取得可辨認資產與負債公允價值之金額；此對價
如低於所取得淨資產公允價值，其差額則認列為當期損益。

商譽於原始認列後，係以成本減累計減損衡量。因企業合併所產生之商譽自取得日起分攤至集團中預期自此合併而受益之
每一現金產生單位，無論被收購者之其他資產或負債是否歸屬於此等現金產生單位。每一受攤商譽之單位或單位群組代表
為內部管理目的監管商譽之最低層級，且不大於彙總前之營運部門。

處分部分包含商譽之現金產生單位時，此處分部分之帳面金額包括與被處分營運有關之商譽。所處分之商譽，係依據該被
處分營運與所保留部分之相對可回收金額予以衡量。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td colspan="2">　 其他</td>
					</tr>
					<tr>
						<td style="text-align:center">項目</td>
						<td style="text-align:center">說明</td>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:Others">
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Item" contextRef="From20220101To20221231" escape="true">公允價值衡量</ix:nonNumeric></pre></td>
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">公允價值係指於衡量日，市場參與者間在有秩序之交易中出售某一資產所能收取或移轉某一負債所需支付之價格。公允價
值衡量假設該出售資產或移轉負債之交易發生於下列市場之一：

(1)該資產或負債之主要市場，或
(2)若無主要市場，該資產或負債之最有利市場

主要或最有利市場必須是集團所能進入以進行交易者。

資產或負債之公允價值衡量係使用市場參與者於定價資產或負債時會使
用之假設，其假設該等市場參與者依其經濟最佳利益為之。

非金融資產之公允價值衡量考量市場參與者藉由將該資產用於其最高及最佳使用或藉由將該資產出售予會將該資產用於其
最高及最佳使用之另一市場參與者，以產生經濟效益之能力。

本集團採用在相關情況下適合且有足夠資料可得之評價技術以衡量公允價值，並最大化攸關可觀察輸入值之使用且最小化
不可觀察輸入值之使用。</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:Others">
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Item" contextRef="From20220101To20221231" escape="true">季節性變化</ix:nonNumeric></pre></td>
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">本集團之營運具有季節性，因為市場對本集團之產品於下半年度需求較高，以致下半年度之營業收入通常較上半年度為高
。</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr>
				</table>
			</div>
			<br />
			<div id="SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">重大會計判斷、假設及估計不確性之主要來源</th>
					</tr> 
					<tr>
						<td>　 重大會計判斷、假設及估計不確性之主要來源</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations" contextRef="From20220101To20221231" escape="true">
本集團編製合併財務報表時，管理階層須於報導期間結束日進行判斷、估計及假設，此將影響收入、費用、資產與負債報
導金額及或有負債之揭露。然而，這些重大假設與估計之不確定性可能導致資產或負債之帳面金額須於未來期間進行重大
調整之結果。

1.估計及假設

  於報導期間結束日對有關未來所作之估計及假設不確定性之主要來源資訊，具有導致資產及負債帳面金額於下一財務年
  度重大調整之重大風險。茲說明如下：

  (1)金融工具之公允價值

     當認列於資產負債表之金融資產及金融負債公允價值無法由活絡市場取得時，公允價值將運用評價技術來決定，包
     括收益法(例如現金流量折現模式)或市場法，這些模式所用之假設變動將會影響所報導金融工具之公允價值。請詳
     附註十二。

  (2)非金融資產之減損

     當資產或現金產生單位之帳面金額大於其可回收金額時，即發生減損。可回收金額係指公允價值減處分成本與使用
     價值，二者孰高者。公允價值減處分成本之計算，是依據於衡量日，市場參與者間在有秩序之交易中出售資產所能
     收取或移轉負債所需支付之價格，經減除直接可歸屬於處分資產或現金產生單位之增額成本後之金額。使用價值是
     基於現金流量折現模式之計算。現金流量之預估係依據未來五年之預算，且不含本集團尚未承諾之重組，或為加強
     該被測試現金產生單位資產績效所需之未來重大投資。可回收金額容易受到現金流量折現模式所使用的折現率及基
     於外推目的所使用之預期未來現金流入與成長率之影響。用以決定不同現金產生單位可回收金額之主要假設，包括
     敏感度分析，請詳附註六之說明。

  (3)退職後福利計畫

     退職後福利計畫之確定福利成本與確定福利義務現值係取決於精算評價。精算評價牽涉各種不同假設，包括：折現
     率及預期薪資之增減變動等。

  (4)所得稅

     所得稅的不確定性存在於對複雜稅務法規之解釋、產生未來課稅所得的金額及時點。由於廣泛的國際商業關係與契
     約的長期性和複雜性，其實際結果與所作假設間產生之差異，或此等假設於未來之改變，可能迫使將已入帳的所得
     稅利益和費用於未來予以調整。對所得稅之提列，係依據本集團營業所在各國之稅捐機關可能的查核結果，所作之
     合理估計。所提列的金額是基於不同因素，例如：以往稅務查核經驗及課稅主體與所屬稅捐機關對稅務法規解釋之
     不同。此解釋之差異，因集團個別企業所在地之情況，而可能產生各種議題。

     未使用之課稅損失與所得稅抵減遞轉後期及可減除暫時性差異，係於未來很有可能產生課稅所得或有應課稅暫時性
     差異之範圍內，認列遞延所得稅資產。決定遞延所得稅資產可認列之金額係以未來課稅所得及應課稅暫時性差異可
     能發生之時點及水準併同未來之稅務規劃策略為估計之依據。

  (5)應收款項–減損損失之估計

     本集團應收款項減損損失之估計係採用存續期間預計信用損失金額衡量，將依據合約可收取之合約現金流量(帳面金
     額)與預期收取之現金流量(評估前瞻資訊)兩者間差額之現值為信用損失，惟短期應收款之折現影響不重大，信用損
     失以未折現之差額衡量。若未來實際現金流量少於預期，可能會產生重大減損損失，請詳附註六。

  (6)存貨評價

     存貨淨變現價值之估計值係考量存貨發生毀損、全部或部分過時或售價下跌等情況，以估計時可得之存貨預期變現
     金額之最可靠證據為之，請詳附註六。

</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>

			<br />
			<div id="TradeAndOtherReceivables"></div>
			<div class="title">應收款項</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='6' rowspan='1' style="text-align:left">明細表</th>
					</tr>
					<tr>
						<th colspan='6' rowspan='1' style="text-align:center">項目及金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">項目</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20221231" escape="true">應收帳款</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,578,837</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,204,966</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20221231" escape="true">應收分期帳款</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,737,055</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,926,537</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20221231" escape="true">減：未實現利息收入-應收分期帳款</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">128,760</ix:nonFraction>)</pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">130,286</ix:nonFraction>)</pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20221231" escape="true">應收租賃帳款</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">52,925</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">62,252</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20221231" escape="true">減：未實現利益</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,109</ix:nonFraction>)</pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,930</ix:nonFraction>)</pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20221231" escape="true">減：備抵損失</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">542,532</ix:nonFraction>)</pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">526,294</ix:nonFraction>)</pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalTradeAndOtherReceivables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,692,416</ix:nonFraction> </pre></td>
						<td colspan='3' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalTradeAndOtherReceivables" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,532,245</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>說明</th>
						<td colspan='4' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ScheduleOfTradeAndOtherReceivables" contextRef="AsOf20221231" escape="true">本集團之應收帳款未有提供擔保之情況。

於民國一一一年十二月三十一日及一一０年十二月三十一日之總帳面金額分別為9,234,948仟元及8,058,539仟元，
於民國一一一年及一一０年備抵損失相關資訊詳附註六.19，信用風險相關資訊請詳附註十二。</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='6' rowspan='1' style="text-align:left">應收款項之帳齡分析</th>
					</tr>
					<tr>
						<th colspan='6' rowspan='1' style="text-align:center">帳齡區間及金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">帳齡區間</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20221231" escape="true">未逾期(註)</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,438,107</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,666,831</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20221231" escape="true">0-60天</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,073,820</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">669,187</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20221231" escape="true">61-90天</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">67,780</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">65,273</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20221231" escape="true">91-180天</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">137,447</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">107,665</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20221231" escape="true">181天以上</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">60,706</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">99,748</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalPastDueButNotImpaired" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,777,860</ix:nonFraction> </pre></td>
						<td colspan='3' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalPastDueButNotImpaired" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,608,704</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>說明</th>
						<td colspan='4' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:AgingAnalysisOfReceivablesThatArePastDueButNotImpaired2" contextRef="AsOf20221231" escape="true">註：本集團之應收票據皆屬未逾期，本集團的應收票據及應收帳款之歷史信用損失經驗顯示部不同客戶群並無顯著不同的損失型態，因此，並不再區分群組。
</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th colspan='3' style="text-align:left">應收款項之備抵損失變動資訊</th> 
					</tr> 
					<tr> 
						<th></th> 
						<th colspan='1'>本期</th> 
						<th colspan='1'>去年同期</th> 
					</tr>
					<tr> 
						<th style="text-align:center"></th> 
						<th style="text-align:center">金額</th>
						<th style="text-align:center">金額</th>
					</tr> 
					<tr>
						<th style="text-align:left">　期初餘額</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance2" contextRef="AsOf20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">526,294</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance2" contextRef="AsOf20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">202,001</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　追溯適用IFRS 9影響數</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EffectOfRetrospectiveApplicationOfIFRS9" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EffectOfRetrospectiveApplicationOfIFRS9" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　提列減損損失</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ProvisionForImpairmentLoss" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,404</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ProvisionForImpairmentLoss" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">384,244</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　減損損失迴轉</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfImpairmentLoss" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfImpairmentLoss" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　因無法收回而沖銷之款項</th>
					　<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:WriteOffsChargedAgainstTheAllowanceAccounts" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">17,353</ix:nonFraction>)</pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:WriteOffsChargedAgainstTheAllowanceAccounts" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">36,755</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　折現轉回數</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfDiscount" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfDiscount" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　匯率影響數</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:CurrencyTranslationDifferences" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,187</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:CurrencyTranslationDifferences" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">23,196</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　其他</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Others1" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Others1" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　期末餘額</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance4" contextRef="AsOf20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">542,532</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance4" contextRef="AsOf20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">526,294</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">說明</th>
						<td  colspan='2' style="text-align:left"></td>
					</tr>
				</table>
			<br />
			<div id="TransactionsBetweenRelatedParties"></div>
			<div class="title">關係人交易</div>
			<div class="rptidx">單位：新臺幣仟元</div>
			<br />
			<div style="text-align:center"> 母公司及最終控制者之名稱</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">關係人名稱及關係</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<br />
			<div class="title">與關係人間之重大交易事項</div>
			<div class="rptidx">單位：新臺幣仟元</div>
			<div style="text-align:center">營業收入</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">進貨</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">應收關係人款項</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">應付關係人款項</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">預付款項</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得不動產、廠房及設備</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分不動產、廠房及設備</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得投資性不動產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分投資性不動產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得金融資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分金融資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得其他資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分其他資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">對關係人放款</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center"> 背書保證</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center"> 其它</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">向關係人借款</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr> 
						<th colspan='3' style="text-align:left">主要管理階層薪酬</th> 
					</tr> 
					<tr> 
						<th></th> 
						<th colspan='1'>本年度</th>
						<th colspan='1'>上年度</th>
					</tr>
					<tr>
						<th style="text-align:left">短期員工福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShortTermEmployeeBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">125,301</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShortTermEmployeeBenefits" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">136,872</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">退職後福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PostEmploymentBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PostEmploymentBenefits" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">其他長期員工福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:OtherLongTermBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:OtherLongTermBenefits" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">離職福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TerminationBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TerminationBenefits" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">股份基礎給付</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShareBasedPayment2" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShareBasedPayment2" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">合計</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalKeyManagementPersonnelCompensation" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">125,301</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalKeyManagementPersonnelCompensation" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">136,872</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">說明</th>
						<td  colspan='3' style="text-align:left"></td>
					</tr>
				</table>
			<br />
			<div id="LoansToOthers"></div>
			<div class="title">資金貸與他人</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='18' rowspan='1' style="text-align:left">資金貸與他人</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">編號</th>
						<th colspan='1' rowspan='2' style="text-align:center">貸出資金之公司</th>
						<th colspan='1' rowspan='2' style="text-align:center">貸與對象</th>
						<th colspan='1' rowspan='2' style="text-align:center">往來項目</th>
						<th colspan='1' rowspan='2' style="text-align:center">是否為關係人</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期最高餘額</th>
						<th colspan='1' rowspan='2' style="text-align:center">期末餘額</th>
						<th colspan='1' rowspan='2' style="text-align:center">實際動支金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">利率區間</th>
						<th colspan='1' rowspan='2' style="text-align:center">資金貸與性質</th>
						<th colspan='1' rowspan='2' style="text-align:center">業務往來金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">有短期融通資金必要之原因</th>
						<th colspan='1' rowspan='2' style="text-align:center">提列備抵呆帳金額</th>
						<th colspan='2' rowspan='1' style="text-align:center">擔保品</th>
						<th colspan='1' rowspan='2' style="text-align:center">對個別對象資金貸與限額</th>
						<th colspan='1' rowspan='2' style="text-align:center">資金貸與總限額</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">價值</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech North America, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">120,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">71,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,639,651</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech (Viet Nam) Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">500</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">289</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Rus Llc</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">141,009</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Denmark Aps</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">82,782</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies Canada Commercial Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">275,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">275,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">152,911</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">190,832</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Philippines, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">20,461</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech UAE L.L.C.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">210,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">210,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">191,680</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">373,797</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies, S.A. de C. V.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">85,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">318,487</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies, Iberica. S.L.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">291,913</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Industrial Do Brasil Ltda.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">660,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">510,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">436,718</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">336,224</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech UK Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">130,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">130,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">770,648</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Hellas S.A.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">50,786</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Italia S.P.A.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">52,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">138,358</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Trading,INC.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,100,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,100,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">765,432</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,737,485</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Turkey Spor VE Saglik Malzemeleri Ticaret Anonim Sirketi</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,065</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,065</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,065</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">0.5</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">營業週轉</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,894,994</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,789,988</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">FUJI MEDICAL INSTRUMENTS MFG. CO., LTD.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">537,740</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">537,740</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">350,700</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">短期融通</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,894,994</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,789,988</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech (Vietnam) Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Style Retail Vietnam Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">22,480</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,842</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,935</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">營業週轉</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">16,659</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">16,659</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech France</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">164,750</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">164,750</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">105,440</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">1.44</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">營業週轉</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">448,251</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">597,668</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. (Thailand) Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">JHT FIT Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,440</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">營業週轉</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">37,820</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">37,820</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">4</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Japan Co., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20220101To20221231" escape="true">Johnson Digital Japan Co., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20220101To20221231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20220101To20221231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">70,140</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">70,140</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,380</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20220101To20221231" escape="true">0.56</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20220101To20221231" escape="true">營業週轉</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80,302</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">240,905</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>母公司資金貸與他人餘額合計</th> 
						<td colspan='21' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalEndingBalance1-Parent" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,856,805</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>子公司資金貸與他人餘額合計</th> 
						<td colspan='21' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalEndingBalance1-Subsidiaries" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">248,732</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>母公司資金貸與他人實際動支金額合計</th> 
						<td colspan='21' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalActualAmountProvided1-Parent" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,155,074</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>子公司資金貸與他人實際動支金額合計</th> 
						<td colspan='21' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalActualAmountProvided1-Subsidiaries" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">140,755</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>備註</th> 
						<td colspan='21' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-LoansToOthers" contextRef="From20220101To20221231" escape="true">註1： 資金貸與性質：1係指有業務往來者，2係指有短期融通資金之必要者。
註2： 喬山健康科技股份有限公司對直接及間接持有表決權股份百分之百之國外子公司之限額，係以依最近財務報表淨值之50%計算。喬山健康科技股份有限公司
　　　對有短期融通資金必要之公司或行號之限額，係以依最近財務報表淨值之20%計算。
　　　Johnson Health Tech (Vietnam) Company Limited對個別對象之限額係以依最近財務報表淨值之100%計算。Johnson Health Tech France對個別對象之限
　　　額係以依最近財務報表淨值之60%計算。Johnson Health Tech. (Thailand) Company Limited對個別對象資金貸與限額依最近期財務報表淨值之40%計算。
　　　Johnson Health Tech Japan Co.,Ltd.對個別對象之限額係以依最近財務報表淨值之20%計算。
註3： 喬山健康科技股份有限公司對直接及間接持有表決權股份百分之百之國外子公司之最高總限額，係以依最近財務報表淨值之100%計算。喬山健康科技股份有
　　　限公司對有短期融通資金必要之公司或行號之最高總限額，係以依最近財務報表淨值之40%計算。
　　　Johnson Health Tech (Vietnam) Company Limited之最高總限額係依最近期財務報表淨值之100%計算，Johnson Health Tech France之最高總限額係依最
　　　近期財務報表淨值之80%計算，Johnson Health Tech. (Thailand) Company Limited之最高總限額係依最近期財務報表淨值之40%計算。Johnson Health 
　　　Tech Japan Co.,Ltd.之最高總限額係依最近期財務報表淨值之60%計算。
註4： 依本公司直接及間接持有表決權股份百分之百之國外公司間，或國外子公司對本公司，因融通資金之必要從事資金貸與時，不受貸與企業淨值之百分之四十
　　　之限制，惟該等子公司應於其訂定之作業程序中載明貸與期限、限額及授權額度。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="EndorsementGuaranteeProvidedToOthers"></div>
			<div class="title">為他人背書保證</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='15' rowspan='1' style="text-align:left">為他人背書保證</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">編號</th>
						<th colspan='1' rowspan='2' style="text-align:center">背書保證者公司名稱</th>
						<th colspan='2' rowspan='1' style="text-align:center">被背書保證對象</th>
						<th colspan='1' rowspan='2' style="text-align:center">對單一企業背書保證限額</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期最高背書保證餘額</th>
						<th colspan='1' rowspan='2' style="text-align:center">期末背書保證餘額</th>
						<th colspan='1' rowspan='2' style="text-align:center">實際動支金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">以財產擔保之背書保證金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">累計背書保證金額佔最近期財務報表淨值之比率</th>
						<th colspan='1' rowspan='2' style="text-align:center">背書保證最高限額</th>
						<th colspan='1' rowspan='2' style="text-align:center">屬母公司對子公司背書保證</th>
						<th colspan='1' rowspan='2' style="text-align:center">屬子公司對母公司背書保證</th>
						<th colspan='1' rowspan='2' style="text-align:center">屬對大陸地區背書保證</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">公司名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">關係</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Johnson Health Tech GmbH</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">290,110</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">287,320</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">3.03</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Johnson Health Tech UK Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">299,065</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">296,935</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">193,495</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">3.13</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">World of Leasing GmbH</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">133,520</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">133,520</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.41</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Iberica S. L.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">300,420</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">300,420</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">273,791</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">3.17</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Japan Co.,Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">49,060</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">46,760</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.49</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. (Thailand) Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">96,690</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">92,280</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45,525</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.97</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. (Schweiz) GmbH</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">161,170</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">159,040</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,048</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.68</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies Canada Commercial Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">146,463</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">136,680</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">56,950</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.44</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Italia S.P.A.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">161,150</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">153,800</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">66,760</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.62</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Johnson Health Industry (VietNam) Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,223,870</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,060,920</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">887,306</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">21.75</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies, S.A. de C.V.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">64,460</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">61,520</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,380</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.65</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Netherlands B.V.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">100,140</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">100,140</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.06</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Johnson Industrial Do Brasil Ltda.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">209,525</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">207,800</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">92,280</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">2.19</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">320,160</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">313,880</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">155,183</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">3.31</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">705,650</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">683,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">37,234</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">7.21</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech North America, Inc.</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Macrolease Corporation</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">130,802</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">71,729</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">71,729</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.76</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech North America, Inc.</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">United Leasing, Inc</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">31,730</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">29,760</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">29,760</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.31</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech North America, Inc</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Lease Servicing Center, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,431</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,294</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,294</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.01</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech North America, Inc</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Mitsubishi HC Capital America, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">171,039</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">171,039</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">171,039</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.81</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Australia Pty. Ltd.</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Eclipx Commercial</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">225</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Australia Pty. Ltd.</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">CE Finance(TL Rentals)</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">432</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Australia Pty. Ltd.</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">CE Finance</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,060</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,060</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,060</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.07</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech France</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">PEAC Finance</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,208</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,208</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,208</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.02</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">4</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies Canada Commercial Inc.</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Meridian OneCap Credit Corp.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,616</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,675</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,675</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.03</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">4</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies Canada Commercial Inc.</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">United Leasing Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,850</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,987</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,987</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.02</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">5</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">喬山健康科技股份公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).3</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">677,850</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">664,800</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">467,600</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">7.02</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">5</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">900,851</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">749,008</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">413,632</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">7.91</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">6</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies Iberica S. L.</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">SG Equipment Finance Iberia, E.F.C., S.A.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">252,301</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">252,301</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">252,301</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">2.66</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">7</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. GmbH</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">PEAC Finance</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,493</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">682</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">682</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.01</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">7</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. GmbH</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">PEAC (Germany) GmbH</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">33,597</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">27,375</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">27,375</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.29</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">8</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Industrial Do Brasil Ltda.</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">Daycoval Leasing</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">93,300</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">86,700</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">52,500</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.92</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">9</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Netherlands B.V.</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">ABC Leasing</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">242,623</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">125,539</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">125,539</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.32</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20220101To20221231" escape="true">10</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20220101To20221231" escape="true">(註1).1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,474,971</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">389,870</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">248,192</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">44,376</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">2.62</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,687,427</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20220101To20221231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20220101To20221231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>母公司背書保證餘額合計</th> 
						<td colspan='18' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalEndingBalance2-Parent" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,034,015</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>子公司背書保證餘額合計</th> 
						<td colspan='18' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalEndingBalance2-Subsidiaries" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,442,349</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>母公司背書保證實際動支金額合計</th> 
						<td colspan='18' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalActualAmountProvided2-Parent" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,857,952</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>子公司背書保證實際動支金額合計</th> 
						<td colspan='18' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalActualAmountProvided2-Subsidiaries" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,671,757</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>備註</th> 
						<td colspan='18' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-EndorsementGuaranteeProvidedToOthers" contextRef="From20220101To20221231" escape="true">註1： 關係1係指有業務關係之公司。
　　　關係2係指直接持有普通股股權超過50%之子公司。
　　　關係3係指母公司與子公司持有普通股股權合併計算超過50%之被投資公司。
註2： 對個別對象限額依最近期財務報表淨值之100%計算。
註3： 背書保證總限額依最近期財務報表淨值之250%計算。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="SignificantIntercompanyTransactionsBetweenConsolidatedEntities"></div>
			<div class="title">母子公司間業務關係及重要交易往來情形</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='8' rowspan='1' style="text-align:left">母子公司間業務關係及重要交易往來情形</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">編號</th>
						<th colspan='1' rowspan='2' style="text-align:center">交易人名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">交易往來對象</th>
						<th colspan='1' rowspan='2' style="text-align:center">與交易人之關係</th>
						<th colspan='4' rowspan='1' style="text-align:center">交易往來情形</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">科目</th>
						<th colspan='1' rowspan='1' style="text-align:center">金額</th>
						<th colspan='1' rowspan='1' style="text-align:center">交易條件</th>
						<th colspan='1' rowspan='1' style="text-align:center">佔合併總營收或總資產之比率</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. North America, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,639,651</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">13.80</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. North America, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,199,417</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">8.23</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. North America, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,691</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.02</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. UK Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">770,641</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">2.29</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. UK Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">654,307</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.68</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. UK Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">479</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. GmbH</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">883,844</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">2.63</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. GmbH</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">337,273</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.87</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. GmbH</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,177</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.01</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Netherlands B.V.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,465,771</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">4.36</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Netherlands B.V.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">241,389</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.62</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Netherlands B.V.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,803</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.01</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech France</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">268,927</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.80</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech France</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">27,692</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" sign="-" decimals="4" unitRef="Pure">0.07</ix:nonFraction>)%</pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech France</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">77</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Australia Pty., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">350,294</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.04</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Australia Pty., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">40,336</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.10</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Australia Pty., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">160</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Industrial do Brasil Ltda</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">336,224</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Industrial do Brasil Ltda</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">334,809</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.86</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Industrial do Brasil Ltda</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">468,285</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.20</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Japan Co., ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">138,443</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.41</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Japan Co., ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,123</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Canada Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">190,832</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.57</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Canada Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">305,454</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.79</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Canada Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">176,752</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.45</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies Iberica, SL</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">291,913</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.87</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies Iberica, SL</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">159,419</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.41</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies Iberica, SL</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,294</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Korea Co., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">138,306</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.41</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Korea Co., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,106</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.04</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Korea Co., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,577</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.03</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Italia S.P.A.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">241,643</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.72</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Italia S.P.A.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">259,859</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.67</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Italia S.P.A.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,470</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.01</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech UAE L.L.C</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">373,797</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.11</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech UAE L.L.C</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">305,660</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.79</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech UAE L.L.C</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">196,292</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.51</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Retail Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">765,432</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">2.28</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Retail Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,208,085</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">8.25</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Retail Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,671</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.02</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies, S.A. de C.V.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">318,487</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.95</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies, S.A. de C.V.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">257,658</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.66</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies, S.A. de C.V.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,706</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.01</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Rus Limited Liability Company</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">141,009</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.42</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Rus Limited Liability Company</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">76,480</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.20</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Industry (Viet Nam) Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">進貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">924,924</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">2.75</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Industry (Viet Nam) Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應付帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">130,906</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.34</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Industry (Viet Nam) Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應付款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">進貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,921,199</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">17.62</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應付帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,394,424</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">8.73</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應付款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">946</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">進貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">520,462</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.55</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應付帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">64,993</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.17</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Industry (Viet Nam) Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">153,932</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.46</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Johnson Health Industry (Viet Nam) Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">147,491</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.38</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">進貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">260,496</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.77</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應付帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">202,800</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.52</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應付款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">200</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">銷貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,562,400</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">4.65</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,404</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.02</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">(註2).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,265</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">與一般客戶交易條件相同</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.01</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='11' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-SignificantIntercompanyTransactionsBetweenConsolidatedEntities" contextRef="From20220101To20221231" escape="true">註1： 母公司及子公司相互間之業務往來資訊應分別於編號欄註明，編號之填寫方法如下：
　　　1.母公司填0。
　　　2.子公司依公司別由阿拉伯數字1開始依序編號。
註2： 與交易人之關係有以下三種，標示種類即可：
　　　1.母公司對子公司。
　　　2.子公司對母公司。
　　　3.子公司對子公司。
註3： 交易往來金額佔合併總營收或總資產比率之計算，若屬資產負債科目者，以期末餘額佔合併總資產之方式計算；若屬損益科目者，以期中累積金額佔合併總營收之方式計算。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence"></div>
			<div class="title">被投資公司名稱、所在地區…等相關資訊</div>
			<div class="rptidx">單位：新臺幣仟元；股數：股</div>
				<table style="width:90%">
					<tr>
						<th colspan='13' rowspan='1' style="text-align:left">被投資公司名稱、所在地區…等相關資訊</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">地區別代號</th>
						<th colspan='1' rowspan='2' style="text-align:center">所在地區</th>
						<th colspan='1' rowspan='2' style="text-align:center">主要營業項目</th>
						<th colspan='2' rowspan='1' style="text-align:center">原始投資金額</th>
						<th colspan='3' rowspan='1' style="text-align:center">期末持股情形</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司本期損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期認列之投資損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期期末</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年年底</th>
						<th colspan='1' rowspan='1' style="text-align:center">股數</th>
						<th colspan='1' rowspan='1' style="text-align:center">比率</th>
						<th colspan='1' rowspan='1' style="text-align:center">帳面金額</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">226</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">英屬維京群島</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">財務投資業務</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,495,256</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,536,240</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,530,425</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">157,174</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">100,074</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">註1、註2</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech (Vietnam) Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">217</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">越南</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">92,706</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">92,706</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,056</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,713</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,713</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies, S.A. de C.V.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">134</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">墨西哥</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">97,924</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">97,924</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">163,651</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">93,165</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">93,165</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Canada Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">29</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">加拿大</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">財務投資業務</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">147,811</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">147,811</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">117,466</ix:nonFraction>)</pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">38,048</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">38,048</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">註1</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. UK Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">210</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">英國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">321,100</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">321,100</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">44.43</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">134,019</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">55,210</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">24,530</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Retail Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,552,050</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,552,050</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">124,372</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">527,660</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">527,660</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">註1</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Care Co., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">104</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">日本</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">按摩椅研發、製造及買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">20,813</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">20,813</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">4,859</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">78.90</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">26,811</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,474</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,209</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Philippines, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">162</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">菲律賓</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">50,440</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">50,440</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">26,883</ix:nonFraction>)</pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">11,501</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">11,501</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Industry  (Viet Nam) Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">217</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">越南</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">健身器材之製造及心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">618,082</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">618,082</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">85,721</ix:nonFraction>)</pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">227,206</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">227,206</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Rus Limited Liability Company</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">37</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">俄羅斯</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">16,949</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">16,949</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">84,789</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">46,817</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">46,817</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Fuji Medical Instruments Mfg. Co., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">104</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">日本</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">按摩椅研發、製造及買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,065,699</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,814,259</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,177,051</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">360,495</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">201,420</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">註3</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. North America, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,019,549</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,019,549</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,115,285</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">78,422</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">78,422</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">PT Johnson Health Tech Indonesia</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">96</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">印尼</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,198</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,198</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,877</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,222</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,222</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Turkey Spor Ve Saglik Malzemeleri Ticaret Anonim Sirketi</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">205</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">土耳其</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">33,120</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">33,120</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.99</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,147</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">585</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">585</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech SA Proprietary Limited.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">183</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">南非</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">55,820</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">55,820</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">38,796</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">10,179</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">10,179</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">JHT FIT Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">199</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">泰國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">影音傳輸及串流服務提供</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,230</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">870</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,351</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,410</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,410</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Digital UK Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">210</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">英國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">影音傳輸及串流服務提供</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">61,800</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">37,494</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">25,656</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">25,656</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Korea Co., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">109</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">南韓</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">27,829</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,305</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,817</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,817</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech India Pvt Ltd</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">95</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">印度</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">22,993</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,717</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">7,512</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">7,512</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">喬山健康科技(香港)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">92</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">香港</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,763</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">3,340,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,449</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,238</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,662</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Fitness (Malaysia) Sdn. Bhd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">124</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">馬來西亞</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">130,489</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">16,052,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.38</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,716</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">26,874</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,793</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. UK Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">210</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">英國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">444,921</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">444,921</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">55.57</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">185,600</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">55,210</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech France</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">227</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">法國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">925,413</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">925,413</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">750,271</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">28,046</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. GmbH</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">78</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">德國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">513,423</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">513,423</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.77</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">465,102</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">13,087</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Technologies Iberica, SL</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">184</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">西班牙</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">770,787</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">770,787</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">446,175</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.99</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">648,544</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,526</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Japan Co., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">104</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">日本</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">235,752</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">235,752</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">13,489</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.78</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">375,512</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">11,332</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. (Thailand) Co., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">199</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">泰國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39,363</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39,363</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">475,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">95.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80,685</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">15,629</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Fitness (Malaysia) Sdn. Bhd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">124</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">馬來西亞</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">130,489</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Italia S.P.A.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">101</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">義大利</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">505,995</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">505,995</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">1,098,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.82</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">545,618</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">33,552</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. (Schweiz) GmbH</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">196</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">瑞士</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">64,780</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">64,780</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">2,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">20,716</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">992</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Netherland B.V.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">145</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">荷蘭</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">539,077</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">539,077</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">18,100</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">674,088</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">91,803</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">喬山健康科技(香港)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">92</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">香港</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,763</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Care Co., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">104</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">日本</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">按摩椅研發、製造及買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,493</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,493</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">400</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">21.10</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,170</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,474</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Industrial do Brasil Ltda.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">22</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">巴西</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">健身器材之製造及外銷業務</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">826,035</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">826,035</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.99</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">177,090</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">83,592</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">World of Leasing GmbH</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">78</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">德國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">46,442</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">46,442</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">167,802</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,892</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Australia Pty., Ltd</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">6</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">澳大利亞</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">573,150</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">573,150</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">20,715,330</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">389,796</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">32,117</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Poland Sp. z o.o.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">163</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">波蘭</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">121,209</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">121,209</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">33,840</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">86,226</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">8,171</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Style Retail Vietnam Company Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">217</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">越南</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,512</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,512</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">27,353</ix:nonFraction>)</pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,325</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson International Holding Corp., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech UAE LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">209</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">阿拉伯聯合大公國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">32,830</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">32,830</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">807</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">24,057</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Retail Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">2nd wind Exercise Equipment, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">657,600</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">657,600</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">754,909</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">121,983</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Retail Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Leisure Fitness Equipment,LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">258,317</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">258,317</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">482,043</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">107,635</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Retail Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">The Gym Store, LLC (Busy Body)</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">150,278</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">150,278</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">113,314</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">49,923</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Retail Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Trading, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">351,886</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">351,886</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">10,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">279,665</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">221,573</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. North America, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech NA Manufacturing LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">健身器材之製造及銷售</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">394,287</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">394,287</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">91,331</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">39,653</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Australia Pty., Ltd</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech New Zealand</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">148</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">紐西蘭</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">100</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">803</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,509</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech. Netherland B.V.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Denmark Aps</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">59</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">丹麥</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">239</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">239</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">50,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">119,569</ix:nonFraction>)</pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">14,619</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Italia S.P.A.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Hellas SA</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">90</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">希臘</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">50,699</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">50,699</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">14,960</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.73</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">48,925</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,297</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Italia S.P.A.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Romania SA</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">169</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">羅馬尼亞</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,058</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,058</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">1,732,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,438</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,329</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Italia S.P.A.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Health Tech CZ ＆ SK a.s.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">58</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">捷克共和國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">心肺復甦健身機與重量訓練機等買賣</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,853</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,853</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">99</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">99.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,550</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,387</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Johnson Health Tech Japan Co., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Johnson Digital Japan Co., Ltd.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">104</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">日本</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">影音傳輸及串流服務提供</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='18' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence" contextRef="From20220101To20221231" escape="true">註1：本期認列被投資公司之投資收益係已包含該等公司認列其再轉投資公司之投資損益。
註2：本期認列被投資公司之投資收益係已包含該等公司因順逆流交易產生之投資損益。
註3：本期認列被投資公司之投資收益係已包含該等公司因側流交易產生之投資損益。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="InvestmentInMainlandChina"></div>
			<div class="title">大陸地區投資</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='14' rowspan='1' style="text-align:left">轉投資大陸地區之事業相關資訊</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">大陸被投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">主要營業項目</th>
						<th colspan='1' rowspan='2' style="text-align:center">實收資本額</th>
						<th colspan='1' rowspan='2' style="text-align:center">投資方式</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期期初自台灣匯出累積投資金額</th>
						<th colspan='2' rowspan='1' style="text-align:center">本期匯出或收回投資金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期期末自台灣匯出累積投資金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司本期損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">本公司直接或間接投資之持股比例</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期認列投資損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">期末投資帳面價值</th>
						<th colspan='1' rowspan='2' style="text-align:center">截至本期止已匯回台灣之投資收益</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">匯出</th>
						<th colspan='1' rowspan='1' style="text-align:center">收回</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:InformationOfInvestmentInMainlandChina">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvesteeInMainlandChina" contextRef="From20220101To20221231" escape="true">喬山健康科技(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">健身器材之製造及內外銷業務</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountOfPaid-inCapital" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,010,296</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MethodOfInvestment" contextRef="From20220101To20221231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheBeginningOfThePeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">748,894</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:InvestmentFlowsForThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Outflow" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Inflow" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheEndOfThePeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">748,894</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">151,852</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnershipThroughDirectAndIndirectInvestmentByTheCompany" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized2" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">151,852</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValueAtTheEndOfThePeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,223,310</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedInwardRemittanceOfEarningsAsOfTheEndOfThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:InformationOfInvestmentInMainlandChina">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvesteeInMainlandChina" contextRef="From20220101To20221231" escape="true">喬山健身器材(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">健身器材之製造及外銷業務</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountOfPaid-inCapital" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,288,274</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MethodOfInvestment" contextRef="From20220101To20221231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheBeginningOfThePeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">62,955</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:InvestmentFlowsForThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Outflow" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Inflow" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheEndOfThePeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">62,955</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">161,026</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnershipThroughDirectAndIndirectInvestmentByTheCompany" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized2" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">161,026</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValueAtTheEndOfThePeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,042,621</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedInwardRemittanceOfEarningsAsOfTheEndOfThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:InformationOfInvestmentInMainlandChina">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvesteeInMainlandChina" contextRef="From20220101To20221231" escape="true">喬山餐飲管理(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">食品販售</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountOfPaid-inCapital" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">72,566</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MethodOfInvestment" contextRef="From20220101To20221231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheBeginningOfThePeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">72,566</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:InvestmentFlowsForThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Outflow" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Inflow" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheEndOfThePeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">72,566</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,459</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnershipThroughDirectAndIndirectInvestmentByTheCompany" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized2" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,459</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValueAtTheEndOfThePeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">36,464</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedInwardRemittanceOfEarningsAsOfTheEndOfThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:InformationOfInvestmentInMainlandChina">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvesteeInMainlandChina" contextRef="From20220101To20221231" escape="true">喬富貿易(上海)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">食品販售</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountOfPaid-inCapital" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">29,905</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MethodOfInvestment" contextRef="From20220101To20221231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheBeginningOfThePeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">29,905</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:InvestmentFlowsForThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Outflow" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Inflow" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheEndOfThePeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">29,905</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">56</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnershipThroughDirectAndIndirectInvestmentByTheCompany" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized2" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">56</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValueAtTheEndOfThePeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,622</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedInwardRemittanceOfEarningsAsOfTheEndOfThePeriod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='17' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-InformationOfInvestmentInMainlandChina" contextRef="From20220101To20221231" escape="true">註1：本公司透過子公司Johnson International Holding Corp., Ltd再投資大陸公司。
註2：本期投資損益係以經台灣母公司會計師核閱之財務報表為依據。
註3：上述金額涉及外幣者，係以資產負債表日之匯率換算為新台幣。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='4' rowspan='1' style="text-align:left">轉投資大陸地區限額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">公司名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">本期期末累計自台灣匯出赴大陸地區投資金額</th>
						<th colspan='1' rowspan='1' style="text-align:center">經濟部投審會核准投資金額</th>
						<th colspan='1' rowspan='1' style="text-align:center">依經濟部投審會規定赴大陸地區投資限額</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LimitOnInvestmentInMainlandChina">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20220101To20221231" escape="true">喬山健康科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedInvestmentInMainlandChinaAtTheEndOfThePeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">914,320</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentAmountAuthorizedByTheInvestmentCommissionOfMOEA" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,501,053</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:UpperLimitOnInvestmentInMainlandChinaImposedByTheInvestmentCommissionOfMOEA" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,684,983</ix:nonFraction> </pre></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='5' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-LimitOnInvestmentInMainlandChina" contextRef="From20220101To20221231" escape="true">本公司於民國一一一年度與大陸被投資公司間所產生之重大交易暨其價格、付款等相關資訊，請參閱附註十三、1及2。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="NonoperatingIncomeAndExpenses"></div>
			<div class="title">營業外收入及支出</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th style="text-align:left" colspan="4">　 利息收入</th>
					</tr>
					<tr>
						<th style="text-align:center">代號</th>
						<th style="text-align:center">會計項目</th>
						<th style="text-align:center">2022年1月1日至12月31日</th>
						<th style="text-align:center">2021年1月1日至12月31日</th>
					</tr>
					<tr>
						<td>N7102</td>
						<td>　　 按攤銷後成本衡量之金融資產利息收入</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncomeFromFinancialAssetsMeasuredAtAmortisedCost_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">165,172</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncomeFromFinancialAssetsMeasuredAtAmortisedCost_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">152,413</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7100</td>
						<td>　　 利息收入合計</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncome_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">165,172</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncome_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">152,413</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br />
				<table style="width:90%">
					<tr>
						<th style="text-align:left" colspan="4">　 其他收入</th>
					</tr>
					<tr>
						<th style="text-align:center">代號</th>
						<th style="text-align:center">會計項目</th>
						<th style="text-align:center">2022年1月1日至12月31日</th>
						<th style="text-align:center">2021年1月1日至12月31日</th>
					</tr>
					<tr>
						<td>N7190</td>
						<td>　　 其他收入－其他</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncomeOthers_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">614,737</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncomeOthers_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">121,116</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7010</td>
						<td>　　 其他收入合計</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncome_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">614,737</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncome_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">121,116</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br />
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th style="text-align:left" colspan="4">　 其他利益及損失</th> 
					</tr> 
					<tr> 
						<th style="text-align:center">代號</th> 
						<th style="text-align:center">會計項目</th> 
						<th style="text-align:center">2022年1月1日至12月31日</th> 
						<th style="text-align:center">2021年1月1日至12月31日</th> 
					</tr>					<tr>
						<td>N7210</td>
						<td>　　 處分不動產、廠房及設備利益(損失)</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfPropertyPlantAndEquipment_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,384</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfPropertyPlantAndEquipment_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,439</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7225</td>
						<td>　　 處分投資利益(損失)</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfInvestments_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">226,390</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfInvestments_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,181</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7230</td>
						<td>　　 外幣兌換利益(損失)</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:ForeignExchangeGainsLosses_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">970,876</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:ForeignExchangeGainsLosses_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">90,975</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<td>N7235</td>
						<td>　　 透過損益按公允價值衡量之金融資產(負債)利益(損失)</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:GainsLossesOnFinancialAssetsOrLiabilitiesAtFairValueThroughProfitOrLoss_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">284</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:GainsLossesOnFinancialAssetsOrLiabilitiesAtFairValueThroughProfitOrLoss_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,901</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<td>N7580</td>
						<td>　　 賠償損失</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:CompensationLosses_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">711,242</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:CompensationLosses_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<td>N7590</td>
						<td>　　 什項支出</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:MiscellaneousDisbursements_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,765</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:MiscellaneousDisbursements_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,279</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<td>N7020</td>
						<td>　　 其他利益及損失淨額</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:OtherGainsAndLosses_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,189</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:OtherGainsAndLosses_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">100,535</ix:nonFraction>)</pre></td>
					</tr>
				</table>
			<br />
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th style="text-align:left" colspan="4">　 財務成本</th> 
					</tr> 
					<tr> 
						<th style="text-align:center">代號</th>
						<th style="text-align:center">會計項目</th> 
						<th style="text-align:center">2022年1月1日至12月31日</th> 
						<th style="text-align:center">2021年1月1日至12月31日</th> 
					</tr> 
					<tr>
						<td>N7510</td>
						<td>　　 利息費用</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestExpense_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">256,180</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestExpense_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">163,482</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7050</td>
						<td>　　 財務成本淨額</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:FinanceCosts_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">256,180</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:FinanceCosts_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">163,482</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br /> 
			</span>
		</div> 
		<br /> 
	</div> 
</body> 
</html> 

<!--This instance document is created by SIIAP V2.4.9-->

